arginine has been researched along with Thrombopenia in 396 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (2.27) | 18.7374 |
| 1990's | 38 (9.60) | 18.2507 |
| 2000's | 191 (48.23) | 29.6817 |
| 2010's | 133 (33.59) | 24.3611 |
| 2020's | 25 (6.31) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, G; Liu, Z; Wang, Y; Yin, L; Zhang, K | 1 |
| Austin Szwak, J; Cirbus, K; Simone, P | 1 |
| Chunara, Z; Guy, S; Hopkins, B; Kitchen, S; Stephenson-Brown, A; van Veen, JJ | 1 |
| Bai, JJ; Deng, CQ; Ding, LH; Li, H; Wei, FY; Wu, BJ; Zhang, L; Zhang, LY; Zhu, XY | 1 |
| Antoku, Y; Koga, T; Nyuta, E; Sakai, T; Takemoto, M; Tsuchihashi, T; Ueno, J | 1 |
| González-Rodríguez, M; Lázaro-García, A; Llamas-Sillero, P; Martínez-Alfonzo, I; Tomás-Mallebrera, M; Velasco-Rodríguez, D; Vidal-Laso, R | 1 |
| Alberio, L; Barelli, S; Gleich, T; Gomez, FJ; Goodyer, M; Grandoni, F; Marchetti, M | 1 |
| Warkentin, TE | 5 |
| Asmis, LM; Bachler, M; Fries, D; Koscielny, J; Lang, T; Nowak, H; Paulus, P; Schewe, JC; von Heymann, C | 1 |
| Briski, MJ; Duewell, BE; Feih, JT; Rinka, JRG; Tawil, JN | 1 |
| Choi, S; Hong, SB; Kim, DK; Oh, DK | 1 |
| Coba, VE; Dingman, JS; Peters, MA; Smith, ZR; To, L | 1 |
| Cho, WH; Kim, DH; Lee, SK; Yeo, HJ | 1 |
| Singh Lubana, S; Singh, N; Tsai, HM | 1 |
| Ambreen, S; Changal, KH; Mir, T; Smith, A | 1 |
| Akiyama, T; Gohma, I; Kohata, H; Kohno, M; Kumasawa, J; Nagata, T; Nishida, K; Ogawa, Y | 1 |
| Fan, Q; Zhang, L; Zhang, Z | 1 |
| Bergis, B; Chanson, N; Chassin, O; Drouot, S; Gleizes, O; Legris, N; Proulle, V; Ract, C; Walle, EM; Werner, M | 1 |
| Lai, CMB; Lee, AYY; Smith, T | 1 |
| Chapman, K; Makhija, K; Prasad, R | 1 |
| Colarossi, G; Hatam, N; Maffulli, N; Migliorini, F; Schnöring, H; Tingart, M; Trivellas, A | 1 |
| Bomalaski, JS; Chen, TY; Cho, SF; Feng, X; Hsiao, HH; Hsu, YT; Johnston, A; Kao, HW; Kuo, MC; Liu, TC; Liu, YC; Tsai, HJ | 1 |
| Fisser, C; Foltan, M; Lubnow, M; Lunz, D; Maier, LS; Malfertheiner, MV; Müller, T; Philipp, A; Winkler, M; Zeman, F | 1 |
| Bersinger, S; Lagarde, K; Marlu, R; Payen, JF; Pernod, G | 1 |
| Cwikla, GM; Darko, W; Feldman, EA; Green, GR; Seabury, RW; Shtoyko, AN | 1 |
| Kolde, HJ; Seidel, H | 1 |
| Laliberte, B; Reed, BN | 1 |
| Lan, X; Li, S; Sun, Z; Tang, Z; Xi, Y; Zhao, H | 1 |
| Dager, WE; Roberts, AJ; Van Cott, EM | 1 |
| Guy, S; Kitchen, S; Van Veen, J | 1 |
| Lopez, ND; Sin, JH | 1 |
| Ahmed, MI; Bethea, BT; Elliot, JW; Richardson, JB | 1 |
| Aliabadi-Zuckermann, A; Dworschak, M; Felli, A; Holaubek, C; Opfermann, P; Panzer, S; Schiferer, A; Steinlechner, B; Wadowski, PP | 1 |
| Gamberini, L; Laici, C; Loforte, A; Ravaioli, M; Siniscalchi, A | 1 |
| Blum, EC; Martz, CR; Nemeh, H; Selektor, Y; Smith, ZR; To, L | 1 |
| Greinacher, A; Heid, J; Katus, HA; Müller, OJ | 1 |
| Gleichgerrcht, E; Lim, MY; Turan, TN | 1 |
| Banik, N; Beyer-Westendorf, J; Brachmann, J; Dohmen, PM; Eberle, S; Hankowitz, J; Klamroth, R; Kropff, S; Lindhoff-Last, E; Madlener, K; Müller, MM; Pötzsch, B; Schellong, S; Schindewolf, M; Steindl, J | 1 |
| Ananth, CV; D'Alton, ME; Eisenberger, AB; Friedman, AM; Sagaram, D; Siddiq, Z; Wright, JD | 1 |
| Abdillah, JN; Chen, X; Hu, Q; Huang, L; Luo, W; Zhou, W | 1 |
| Al-Eidan, FAS; Alrawkan, S; Alshammary, H; Crowther, MA | 1 |
| Ascaso, M; Pereda, D; Quintana, E; Sandoval, E | 1 |
| Prince, M; Wenham, T | 1 |
| Aissaoui, N; Ajzenberg, N; Amour, J; Besnier, E; Borie, M; Bougon, D; Chardonnal, L; Delmas, C; Dessertaine, G; Girerd, N; Grisot, PH; Guidon, C; Helms, J; Kimmoun, A; Labro, G; Lamiral, Z; Levy, B; Medard, A; Megarbane, B; Mongardon, N; Nesseler, N; Ouattara, A; Oulehri, W; Pierrot, M; Renou, A; Rozec, B; Schmidt, M; Sonneville, R; Zogheib, E | 1 |
| Cao, WC; Chen, WW; Cui, N; Du, J; Hu, Z; Li, H; Li, XK; Liu, R; Liu, W; Lu, QB; Xing, B; Xu, W; Xu, Z; Yang, ZD; Yao, K; Yuan, C; Zhai, D; Zhang, PH; Zhang, SF; Zhang, XA | 1 |
| Ahadizadeh, EN; Buethe, DJ; Honda, K; Manzoor, NF; Merati, M; Mowry, SE; Semaan, M | 1 |
| Cho, YH; Chung, CR; Kim, YS; Lee, H; Suh, GY; Sung, K; Yang, JH | 1 |
| Arepally, GM; Chong, BH; Cines, DB; Cuker, A; Greinacher, A; Gruel, Y; Linkins, LA; Morgan, RL; Mustafa, RA; Rodner, SB; Santesso, N; Selleng, S; Warkentin, TE; Wex, A | 1 |
| Forman, DA; Mohanty, E; Nazir, S; Sheppard, JI; Warkentin, TE | 1 |
| Hage, A; Kiaii, B; Louzada, M | 1 |
| Van Cott, EM; Villalba, JA | 1 |
| Arays, R; McCarthy, P; Shmookler, AD | 1 |
| Chandler, W; Hart, SR; Liebl, MG; Putney, D; Wanat, MA | 1 |
| Fukada, Y; Hirota, M; Hoshino, J; Isomura, T; Kondo, T | 1 |
| Fukata, M; Furukawa, H; Konishi, T; Kurosaki, K; Okada, H; Sakagami, N | 1 |
| Matsumoto, K; Nakagawachi, A; Sakaguchi, Y; Tanigawa, Y; Torikai, A; Yamada, T | 1 |
| Arpino, PA; Fatalo, A; Goeller, AJ; Van Cott, EM | 1 |
| Alaraj, A; Aletich, V; Birk, D; Tobin, M | 1 |
| Burger, CF; Schlesinger, JJ | 1 |
| Ashton, RF; Cairns, BA; Charles, AG; Khoury, AI; Phillips, MR | 1 |
| Hatakeyama, M; Munakata, M; Ono, Y | 1 |
| Coventry, DA; Webster, NR | 1 |
| Fabris, F; Furian, L; Nordio, M; Treleani, M; Vianello, F | 1 |
| Hirade, R; Mihara, T; Nikai, T; Ota, J; Saito, Y; Sakakibara, S | 1 |
| Dee, B; Gulbis, A; Lombardi Thomas, L | 1 |
| Bartholomew, JR; Casanegra, AI; Dhariwal, M; Gomes, MP; Gornik, HL; Joseph, L; Militello, MA; Raju, MG; Smith, MA | 1 |
| Ayausty-Ruiz, A; Calzón-Blanco, C; Pablos-de Pablo, M; Quiñones-Ortiz, L; Quiñones-Pérez, S; Robles, V; Suárez-Laurés, A | 1 |
| Forsyth, LL; Shannon, F; Sheppard, JA; Smith, MD; Smythe, MA; Warkentin, TE | 1 |
| Moffett, BS; Teruya, J | 1 |
| Bahlmann, A; Beiderlinden, M; Brezina, T; Geib, J; Golla, E; Greinacher, A; Kienbaum, P; Kindgen-Milles, D; Pannen, B; Schaefer, MS; Treschan, TA; Werner, P | 1 |
| Bhalla, MC; Frey, JA; Hourmouzis, Z; Jwayyed, S | 1 |
| Lin, JK; Tong, LM; Vo, QA | 1 |
| Baumgarten, G; Boehm, O; Graeff, I; Hoeft, A; Kim, SC; Schewe, JC; Tran, N; Wittmann, M | 1 |
| Bojic, D; Drmic, D; Hrelec Patrlj, M; Kokot, A; Kolenc, D; Radic, B; Seiwerth, S; Sikiric, P; Stupnisek, M; Suran, J; Vcev, A; Zenko Sever, A | 1 |
| Adams, CD; Anne Hirning, B; Blum, RM; Fanikos, J; Gilmore, JF; Matta, L | 1 |
| Hillebrand, J; Martens, S; Mesters, R; Scherer, M; Schmidt, C; Sindermann, J | 1 |
| Ito, S; McAlister, RK | 1 |
| Greinacher, A | 2 |
| Bain, J; Meyer, A | 1 |
| Li, Q; Peng, J; Wei, S; Wu, W; Zhou, J | 1 |
| Epperla, N; Jayarangaiah, A | 1 |
| Biron-Andréani, C; de Maistre, E; Grosjean, S; Gruel, Y; Grunebaum, L; Morange, PE; Morel, J; Nguyen, P; Tardy-Poncet, B; Thiranos, JC; Villacorta-Torres, J; Wynckel, A | 1 |
| Albers, EL; Dickey, R; Falconer, A; Jefferis Kirk, C; Latham, GJ; McMullan, DM | 1 |
| Imoto, K; Isoda, S; Karube, N; Masuda, M; Matsuki, Y; Uchida, K; Yasuda, S | 1 |
| Bek, MJ; Keyl, C; Trenk, D; Wiessner, M; Zimmer, E | 1 |
| Alaniz, C; Chan, C; Dorsch, M; Jaynes, E; Pipe, S; Vu, N | 1 |
| Gates, C; Neave, L; Scully, M | 1 |
| Kyle, JA; Roberts, RA; Skelley, JW | 1 |
| Adams, DH; Evans, AS; Fischer, GW; Heller, J; Salter, BS; Trinh, MA; Weiner, MM | 1 |
| Beiderlinden, M; Brau, C; di Grazia, S; Treschan, TA; Wehmeier, M | 1 |
| Croci, E; Dentali, F; Giorgi-Pierfranceschi, M; Mumoli, N; Scarpioni, R | 1 |
| Harada, MY; Hoang, DM; Ley, EJ; Margulies, DR; Mason, R; Murry, JS; Nuño, M; Sun, BJ; Volod, O; Zaw, AA | 1 |
| Kin, N; Mitomo, S; Naganuma, T; Nakamura, S | 1 |
| Keyl, C; Lehane, C; Trenk, D; Zimmer, E | 1 |
| Kang, KP; Kim, W; Lee, S; Lim, JH; Park, SK | 1 |
| Lei, BZ; Sendowski, M; Shatzel, JJ | 1 |
| Baumgarten, G; Kim, S; Koster, A; Riedel, R; Schewe, JC; Schmieder, A | 1 |
| Alarcón Pérez, L; Duque González, P; Rodríguez Huerta, AM | 1 |
| Baron, SJ; Cruz-Gonzalez, I; Drachman, D; Garasic, J; Healy, JL; Jang, IK; Pomerantsev, E; Rosenfield, K; Yeh, RW | 1 |
| Bauer, KA; Donati, MB; Gould, M; Hirsh, J; Samama, MM; Weitz, JI | 1 |
| Colemen, CI; Talati, R; White, CM | 1 |
| Baron, SJ; Cruz-Gonzalez, I; Healy, JL; Jang, IK; Osakabe, M; Sanchez-Ledesma, M; Watanabe, H; Yeh, RW | 2 |
| Boggio, LN; Oza, VM | 1 |
| Lineaweaver, WC; Oswald, TM; Schleich, AR | 1 |
| Bakhos, M; Hoppensteadt, D; Iqbal, O; Jeske, WP; Maddineni, J; Messmore, HL; Prechel, M; Walenga, JM | 1 |
| Byrne, JG; Eagle, SS; Greelish, JP; Warhoover, MT; Webb, DP; Zhao, DX | 1 |
| Greinacher, A; Haneya, A; Hirt, S; Schmid, C; Selleng, K; Selleng, S | 1 |
| Jiji, RS; Michaels, AD | 1 |
| Billett, HH; Cheng-Lai, A; Curzio, KM; Kheyfets, V; Sinnet, M | 1 |
| Hursting, MJ; Jang, IK | 3 |
| Buerke, M; Janusch, M; Maegdefessel, L; Raaz, U; Schlitt, A; Werdan, K | 1 |
| Böhm, M; Girndt, M; Link, A; Mathes, A; Rensing, H; Selejan, S | 1 |
| Taimeh, Z; Weksler, B | 1 |
| Hursting, MJ; Verme-Gibboney, CN | 1 |
| Murray, PT | 1 |
| Ernst, NE; Gallagher, EM; Keegan, SP; Mueller, EW; Young, EJ | 1 |
| Ansara, AJ; Arif, S; Warhurst, RD | 1 |
| Kapa, S; Qian, Q | 1 |
| Chong, BH; Isaacs, A | 1 |
| Ishida, H; Yamazaki, T | 1 |
| Matsuo, T; Sugimoto, T; Wanaka, K | 1 |
| Heslet, L; Nielsen, JD | 1 |
| Christoffersen, C; Gøtze, JP; Lethagen, S | 1 |
| Hursting, MJ; Soffer, J | 1 |
| Aloia, TA; Goss, JA | 1 |
| Buerke, M; Friedrich, I; Hamilton, K; Hauroeder, B; Linde, T; Maegdefessel, L; Michel, T; Raaz, U; Schlitt, A; Schubert, S; Steinseifer, U; Werdan, K | 1 |
| Chong, BH; Lip, GYH; Shantsila, E | 1 |
| Asaro, LR; Ekbatani, A; Malinow, AM | 1 |
| Bara, C; Gras, C; Hafer, C; Haverich, A; Kuehn, C; Malehsa, D; Meyer, AL; Strüber, M | 1 |
| Dhillon, S | 1 |
| Cheng, GS; Fan, FL; Ma, Q; Meng, Y; Tian, HY; Wan, HM; Wang, J; Zhang, JB | 1 |
| Balasubramaniam, M; Forsyth, LL; Koerber, JM; Mattson, JC; Priziola, JL; Smythe, MA | 1 |
| Arai, T; Chiba, A; Okuda, Y; Saima, S; Saito, T; Uchida, E | 1 |
| Ichinoe, M; Mikami, T; Okayasu, I; Suzuki, K; Ujiie, S | 1 |
| Heil, S | 1 |
| Levy, JH; Winkler, AM | 1 |
| Barash, P; Coady, M; Fareed, J; Genzen, JR; Hoppensteadt, D; Kurup, V; Wu, YY | 1 |
| Ortel, TL | 1 |
| D'Ancona, G; Filippone, G; Floriano, M; Follis, F; Follis, M; Lobianco, E; Montalbano, G | 1 |
| Bécanne, X; De Mesmay, M; Flaujac, C; Gauzit, R; Godier, A; Horellou, MH; Parisot, M; Samama, CM | 1 |
| Azuma, K; Hayashida, M; Imanishi, H; Kitamura, A; Maruyama, K; Nakagawa, H | 1 |
| Alatri, A; Foramitti, M; Paoletti, O; Testa, S; Zimmermann, A | 1 |
| Bartholomew, JR; Frame, JN; Rice, L; Whelton, A | 1 |
| Huber, W; Moessmer, G; Phillip, V; Saugel, B; Schmid, RM | 1 |
| Kawamura, M; Masai, T; Matsue, H; Yoshikawa, Y | 1 |
| Fukuda, S; Kigawa, I; Miyairi, T; Okamura, Y | 1 |
| Hanson, GW; Malias, MA; Mitchell, GA; Sparkman, GM; Stowe, CL; Terneus, WF; Wellborn-Kim, JJ | 1 |
| Babuin, L; Pengo, V | 1 |
| Carlson, KB; DeSancho, MT; Mallik, A | 1 |
| Bandyk, DF; Bartholomew, JR; Boyce, SW; Frame, JN; Rice, L | 1 |
| Fareed, J; Hoppensteadt, DA; Jeske, WP; Lewis, B; Walenga, JM | 1 |
| Arnold, H; Deal, EN; Hollands, JM; Martinez, EJ; Micek, ST; Skrupky, LP; Smith, JR | 1 |
| Oo, TH | 1 |
| Behr, J; Beiras-Fernandez, A; Dolch, ME; Frey, L; Hatz, R; Irlbeck, M; Lung Transplant Group, TM; Uberfuhr, PA | 1 |
| Bauerfeind, U; Knüttgen, D; Lange, J; Sakka, SG; Stoelben, E; Wappler, F | 1 |
| Smythe, MA; Warkentin, TE; Woodhouse, AL; Zakalik, D | 1 |
| Hassell, KL; Kiser, TH; Mann, AM; Trujillo, TC | 1 |
| Jain, PG; Kauflin, MJ; Nanda, MM; Yannetta, JC | 1 |
| Fries, D | 1 |
| Antovic, JP; Armstrong, E; Baghaei, F; Dalsgaard-Nielsen, J; Hillarp, A; Holme, PA; Holmström, M; Johnsson, H; Joutsi-Korhonen, L; Lassila, R; Sandset, PM | 1 |
| Boshkov, LK; Boyle, DA; Cox, DS; Hursting, MJ; Kallender, H; Raffini, LJ; Soffer, J; Sullivan, JE; Tarka, EA; Young, G | 1 |
| Darki, A; Jacobs, W; Kodali, PP; McPheters, JP; Patel, MR; Virk, H | 1 |
| Donovan, JL; Kanaan, AO; Tran, MT | 1 |
| Böhm, M; Link, A; Pöss, J | 1 |
| Accrocca, F; Antonelli, R; Gabrielli, R; Giordano, GA; Marcucci, G; Rosati, MS; Siani, A | 1 |
| Faust, AC; Oliphant, CS | 1 |
| Kennedy, K; King, S; Poe, K; Reeves, J; Short, M; Steinke, D | 1 |
| Alatri, A; Armstrong, AE; Greinacher, A; Koster, A; Kozek-Langenecker, SA; Lancé, MD; Link, A; Nielsen, JD; Sandset, PM; Spanjersberg, AJ; Spannagl, M | 1 |
| Haas, S; Lewis, B | 1 |
| Haeberle, L; Nohe, B; Ploppa, A; Schmid, E | 1 |
| Corbets, LR; Forsyth, LL; Koerber, JM; Mehta, TP; Melendy, SM; Parikh, R; Smythe, MA; Sykes, E | 1 |
| Barbosa, JB; Brunini, TM; Mann, GE; Matsuura, C; Mendes-Ribeiro, AC; Moraes, TL; Moss, MB; Neto, ML; Siqueira, MA | 1 |
| Demma, LJ; Levy, JH; Paciullo, CA | 1 |
| Hetzer, R; Koster, A; Krabatsch, T; Maj, G; Pappalardo, F; Potapov, E; Scandroglio, AM; Stepanenko, A; Zangrillo, A | 1 |
| Ebina, Y; Miyata, S; Morita, H; Sonoyama, A; Tanimura, K; Yamada, H | 1 |
| Gulseth, MP; Hellwig, TR; Peitz, GJ | 1 |
| Asai, Y; Doi, M; Murawaki, A; Nakashima, K; Nakayasu, H; Omura, H; Suzuki-Kinoshita, K | 1 |
| Goto, S; Hiramori, T; Kuroiwa, K; Mochizuki, N; Nishizawa, M; Takano, T | 1 |
| Chakraborty, AK; Griffin, DK; Sheppard, JA; Warkentin, TE | 1 |
| Benken, ST; Kim, KS; Mucksavage, JJ; Tesoro, EP | 1 |
| Kasirajan, K | 1 |
| Knovich, MA; Lesser, GJ; Strowd, RE | 1 |
| Argueta-Morales, IR; DeCampli, WM; Felix, DE; Munro, HM; Olsen, MC | 1 |
| Abel, EE; Kane-Gill, SL; Kellum, JA; Seybert, AL | 1 |
| Cruz-González, I; López-Jiménez, R; Perez-Rivera, A; Yan, BP | 1 |
| Rondina, MT; Varedi, A; Walker, A; Yarbrough, PM | 1 |
| Cooper, T; Kokko, H; Mazur, J; Taber, D; Uber, WE; White, CL | 1 |
| Akrour, M; Chapelle, C; Combe, M; Piot, M; Tardy, B; Tardy-Poncet, B | 1 |
| Matsuo, T | 3 |
| Smythe, MA; Warkentin, TE | 1 |
| Jeske, WP; Walenga, JM | 1 |
| Breddin, HK | 1 |
| Mattson, JC; Smythe, MA; Stephens, JL; Warkentin, TE; Zakalik, D | 1 |
| Cohen, M; Hursting, MJ; Lewis, BE; Leya, F; Matthai, WH; Moses, JW | 1 |
| Bittl, JA | 1 |
| Nguyen, PH; Rice, L; Vann, AR | 1 |
| Ahmad, S; Fareed, J; Iqbal, O; Lewis, BE; Rangel, Y; Walenga, JM | 1 |
| Mukundan, S; Zeigler, ZR | 1 |
| Greinacher, A; Lubenow, N | 2 |
| Aizawa, Y; Fuse, I; Hanzawa, K; Hayashi, J; Higuchi, K; Hori, T; Matsubara, T; Mezaki, T; Moro, H; Nasuno, A; Tanaka, K; Tanaka, T; Tsuchida, K | 1 |
| Huber, L; Johnston, N; Wait, M | 1 |
| Eichler, P; Greinacher, A; Lubenow, N; Müllejans, B; Selleng, S; Wollert, HG | 1 |
| Holman, WL; Kieta, DR; McCammon, AT; Nielsen, VG | 1 |
| Dolinski, SY; Kincaid, EH; MacGregor, DA; Reichert, MG | 1 |
| Edwards, JT; Hamby, JK; Worrall, NK | 1 |
| Walenga, JM | 1 |
| Lewis, BE; Walenga, JM | 1 |
| Higuma, N; Honsako, A; Miida, T; Oda, H; Sakai, K; Takahashi, K | 1 |
| Satler, LF | 1 |
| Miller, PL | 1 |
| Dager, WE; White, RH | 2 |
| Matsumoto, M; Matsuo, T; Matsuyama, K; Nishizawa, J; Sugita, T; Tokuda, Y; Yoshida, K | 1 |
| Cleveland, KW | 1 |
| Arruda, MJ; Cetta, F; Graham, LC; Walenga, JM; Wrona, LL | 1 |
| Koller, J; Malherbe, S; Stobart, K; Tsui, BC | 1 |
| Heddle, N; Hirsh, J; Kelton, JG | 1 |
| Albert, M; Boulanger, I; Grégoire, G; Tardif, M; Williamson, DR | 1 |
| Brown, PM; Hursting, MJ; LaMonte, MP | 2 |
| Call, JT; Deliargyris, EN; Sane, DC | 1 |
| Dangas, GD; Nikolsky, E | 1 |
| Boshkov, L; Giacomuzzi, C; Heller, E; Mejak, B; Shen, I; Ungerleider, R; You, X | 1 |
| Hayashi, T; Kaneko, M; Nakao, Y; Nomura, T; Nonaka, Y; Okamura, J; Suyama, Y | 1 |
| Stafford-Smith, M; Welsby, IJ | 1 |
| Fujisawa, M; Makita, K; Nakazawa, K | 1 |
| Aranki, SF; Fitzgerald, D; Gasparovic, H; Nathan, NS | 1 |
| Kaiser, LR; Shrager, JB | 1 |
| Damiano, RJ; Deshpande, SP; Lawton, JS; Zanaboni, PB | 1 |
| Cox, DS; Murray, PT; Nahlik, L; Patel, K; Reddy, BV; Tang, IY; Trevino, S | 1 |
| Bartholomew, JR | 1 |
| Dubb, JW; Verme-Gibboney, C | 1 |
| Hallman, SE; Hebbar, L; Robison, J; Uber, WE | 1 |
| Dyke, PC; Mureebe, L; Russo, J; Russo, P; Tobias, JD | 1 |
| Woodyard, DN | 1 |
| Almahameed, A; Bartholomew, JR; Begelman, SM | 1 |
| Francis, JL; Hursting, MJ | 1 |
| Hursting, MJ; Kelton, JG; Lewis, BE; Matthai, WH | 1 |
| Dorion, RP; Gilbert, C; Klayman, M; Murdock, JD; Stammers, AH; Trowbridge, C; Woods, E; Yen, B | 1 |
| Fenyvesi, T; Harenberg, J; Ingrid, J; Job, H; Jörg, I; Lukas, P; Piazolo, L; Tivadar, F | 1 |
| Knoblauch, R; Pollak, ES; Russell, JE | 1 |
| Hursting, MJ; Lewis, BE; Macfarlane, DE | 1 |
| Bartholomew, JR; Hursting, MJ | 1 |
| De Mattia, D; De Santis, A; Del Vecchio, GC; Giordani, L | 1 |
| Abrams, CS; Pollak, ES | 1 |
| Asada, R; Matsuo, T; Wanaka, K | 1 |
| Rice, L | 1 |
| Grossman, EJ; Hursting, MJ; Murray, PT; Reddy, BV; Trevino, SA | 1 |
| Smith, KM; Taylor, LM | 1 |
| McIntosh, BA | 1 |
| Hyers, TM | 1 |
| Hallisey, RK; John, TE | 1 |
| Katz, E; Kim, KY; McNulty, I | 1 |
| Fish, DN; Jung, R; Kiser, TH; MacLaren, R | 1 |
| Aghababian, RV; Begelman, SM; Hursting, MJ; McCollum, D | 1 |
| Malinin, AI; Serebruany, MV; Serebruany, VL | 1 |
| Bauer, C; Kleinschmidt, S; Pindur, G; Stephan, B | 1 |
| Matthai, WH | 3 |
| Kuter, DJ; Yee, AJ | 1 |
| Conrad, SA; Grier, LR; Scott, LK | 1 |
| Ichikawa, M; Imanaka, H; Minatoya, K; Miyata, S; Morishita, H; Ogino, H; Okamoto, A; Oue, M | 1 |
| Baker, KM; Flattery, MP | 1 |
| Dang, CH; Durkalski, VL; Nappi, JM | 1 |
| Pendleton, R; Rodgers, GM; Wheeler, MM | 1 |
| Hursting, MJ; Levine, RL; McCollum, D | 1 |
| Bozzo, J; Escolar, G; Maragall, S | 1 |
| Gurley, WQ; Kirklin, JK; Lell, WA; Nielsen, VG; Pereira, SJ; Steenwyk, BL | 1 |
| Boshkov, LK; Kirby, A; Shen, I; Ungerleider, RM | 1 |
| Barash, P; Dewar, M; Kurup, V; Rinder, HM; Transue, S; Wu, Y | 1 |
| Warkentin, TW | 1 |
| Hursting, MJ; Levine, RL; Lewis, BE; Leya, F; Wallis, DE | 1 |
| Hein, OV; Schönfeld, H | 1 |
| Das, P; Hamdalla, H; Jozic, J; Moliterno, DJ; Mukherjee, D; Steinhubl, SR; Ziada, K | 1 |
| Breddin, K; Buz, S; Harder, S; Hetzer, R; Koster, A; Kuppe, H | 1 |
| Kaneko, M; Kohno, H; Muraoka, M; Shikata, H | 1 |
| Hursting, MJ; Murray, PT | 1 |
| Almahameed, A; Napolitano, LM; Nasraway, SA; Warkentin, TE | 1 |
| Guzzi, LM; Hursting, MJ; McCollum, DA | 1 |
| Cooney, MF | 1 |
| Durr, EA; Krueger, CD; Shapiro, NL | 1 |
| Kirklin, JK; Nielsen, VG | 1 |
| Hursting, MJ; Lewis, BE | 1 |
| Fraser, JF; O'Connor, ED | 1 |
| Haas, S; Höhnke, C | 1 |
| Marymont, JH; Murphy, GS | 1 |
| Greinacher, A; Selleng, K; Warkentin, TE | 1 |
| Dager, WE; Dougherty, JA; Militello, MA; Nguyen, PH; Smythe, MA | 1 |
| Potter, KE; Raj, A; Sullivan, JE | 1 |
| Beiderlinden, M; Görlinger, K; Peters, J; Treschan, TA | 1 |
| Davenport, A | 1 |
| Fischer, KG; Groman, T; Harder, S; Hentschel, T; Hetzer, R; Koster, A; Kuppe, H | 1 |
| Baillie, GM; Hursting, MJ; McCollum, DA; Rice, L | 1 |
| Beiderlinden, M; Görlinger, K; Peters, J; Treschan, T | 1 |
| Bong, M; Di Cesare, PE; Patel, VP | 1 |
| Bartholomew, JR; Hursting, MJ; Pietrangeli, CE | 1 |
| Beyer, J; Halbritter, K; Leonhard, J; Schellong, S; Weise, M | 1 |
| Harder, S; Klinkhardt, U; Koster, A; Lorenz, H; Merz, M | 1 |
| Hursting, MJ; Jang, IK; McCollum, D | 1 |
| Ahmed, I; Majeed, A; Powell, R | 1 |
| Jolicoeur, EM; Lopes, RD; Ohman, EM; Wang, T | 1 |
| Curvers, J; Keuren, JF; Magdeleyns, EJ | 1 |
| Balduini, CL; De Candia, E; Savoia, A | 1 |
| Cappellini, MD; Cassinerio, E; Castelli, R; Fabris, F; Graziadei, G; Porro, F | 1 |
| Agnelli, G; Filippucci, E; Iorio, A; Vedovati, MC | 1 |
| Athar, U; Gajra, A; Hudson, J; Husain, J; Lynch, J | 1 |
| Gray, A; Hursting, MJ; Katz, E; Lewis, BE; Wallis, DE | 1 |
| Cruz-González, I; Jang, IK; Sánchez, PL; Sánchez-Ledesma, M | 1 |
| Fujita, S; Itonaga, T; Masumoto, H; Nakai, M; Nomura, R; Shimamoto, M; Yamazaki, F | 1 |
| Bozlar, U; Simsek, S; Turba, UC | 1 |
| Matsuo, T; Wanaka, K | 1 |
| Allen, SL; Barginear, MF; Bhaskaran, M; Bradley, T; Budman, DR; Donahue, L; Shapira, I | 1 |
| Levine, RL; Pivalizza, EG; Zayac, EA | 1 |
| Exner, HJ; Fehske, W; Görlinger, K; Lutz, JT; Schannewitzky, A | 1 |
| Chiappe, J; Fugate, S | 1 |
| Bellmann, R; Dunzendorfer, S; Joannidis, M; Pechlaner, C; Schusterschitz, N; Stein, M | 1 |
| Czyz, Y; Hoffman, WD; Hursting, MJ; McCollum, DA | 1 |
| Prechel, M; Walenga, JM | 1 |
| Rolfes, C; Steinfeldt, T | 1 |
| Casanova-Ghosh, E; Ferdinand, F; Garwood, P; Goldman, SM; Hagan, K; Kohout, J; Samuels, LE | 1 |
| Butterworth, J | 1 |
| Hertelendy, F; Molnár, M; Sütö, T; Tóth, T | 1 |
| Alak, AM; Cromeens, DM; Flaherty, MJ; Griffith, OW; Gross, SS; Kilbourn, RG; Owen-Schaub, LB; Santee, SM | 1 |
| Kolluri, R; Lamhonwah, AM; Peacocke, M; Shehabeldin, A; Siminovitch, KA; Teichert-Kuliszewska, K; Weissman, SM | 1 |
| Blaese, RM; Hagemann, TL; Knutsen, A; Kwan, SP; Rosen, FS | 1 |
| Nawarskas, JJ; Spinler, SA | 1 |
| Ahmed, A; Anderson, CL; Brandt, JT; Isenhart, CE; Osborne, JM | 1 |
| Donkin, J; Iaffaldano, R; Lewis, BE; McKiernan, TL; Rao, L; Wallenga, JM | 1 |
| Grassman, ED; Lewis, BE; Rangel, Y; Wrona, L | 1 |
| Lewis, BE; Walenga, JM; Wallis, DE | 1 |
| Kario, K; Koide, M; Matsuo, T | 1 |
| Fareed, J; Hoppensteadt, DA; Kahn, S | 1 |
| Fareed, J; Lewis, BE; Rangel, Y | 1 |
| Aiach, M; Bachelot-Loza, C; Chatellier, G; Lasne, D; Rendu, F; Saffroy, R | 1 |
| Fujii, K; Koide, M; Matsuo, M; Matsuo, T; Sakamoto, S; Suzuki, S | 1 |
| Koide, M; Matsuo, T | 1 |
| Chong, BH; Ortel, TL | 1 |
| Ahmad, S; Callas, D; Fareed, J; Haas, S; Hoppensteadt, DA; Jeske, WP; Lietz, H; Messmore, HL; Walenga, JM | 1 |
| Bakhos, M; Fareed, J; Jeske, WP; Lewis, BE; Leya, F; Walenga, JM; Wallis, DE | 1 |
| Jang, IK; Januzzi, JL | 1 |
| Arnoletti, JP; Whitman, GJ | 1 |
| Miller, JL | 1 |
| Bartholomew, J; Berkowitz, SD; Fareed, J; Hursting, MJ; Jang, IK; Kelton, JG; Lerner, RG; Lewis, BE; Matthai, WH; Moran, J; Rifkin, SD; Rustagi, PK; Sham, R; Walenga, JM; Wallis, DE; Zeigler, ZR | 1 |
| Kondo, LM; Wiggins, BS; Wittkowsky, AK | 1 |
| Baglin, TP | 1 |
| McKeage, K; Plosker, GL | 1 |
| Corno, A; Horisberger, J; Marty, B; Mueller, X; von Segesser, LK | 1 |
| Aida, H; Aoki, Y; Ohki, I; Tanaka, K | 1 |
| Ohno, H; Yokoi, M | 1 |
| Jang, IK; Kathiresan, S; Shiomura, J | 1 |
| Ahmad, S; Hoppensteadt, D; Hursting, MJ; Iqbal, O; Lewis, BE; Walenga, JM | 1 |
| Mendez, MN; Tong, LM | 1 |
| Chikahira, Y; Kario, K; Matsuo, T; Nakao, K; Yamada, T | 1 |
| Kario, K; Kodama, K; Matsuo, T; Okamoto, S | 1 |
| Matsuo, T; Ryo, R; Yamada, T; Yamanashi, T | 1 |
| Chikahira, Y; Matsuo, O; Matsuo, T; Nakao, K; Ueshima, S; Yamada, T | 1 |
| Matsuo, O; Matsuo, T; Nakao, K; Yamada, T | 1 |
| Chen, ZP; Jiang, XB; Mu, YG; Sai, K; Shen, D; Yang, QY; Zhang, XH | 1 |
| Fievet, MH; Gabarre, J; Junot, H; Malliti, M; Taright, N; Thuillier, A; Vernant, JP | 1 |
| Basso, U; Brandes, AA; Ermani, M; Jirillo, A; Koussis, H; Lonardi, S; Monfardini, S; Paris, MK; Pasetto, LM; Tosoni, A; Vastola, F | 1 |
| Carbone, A; Crivellari, D; Franchin, G; Galligioni, E; Grigoletto, E; Tirelli, U; Trovò, M; Tumolo, S; Veronesi, A; Volpe, R | 1 |
| Schulz, JJ; Speckhart, VJ; Spremulli, E; Wampler, GL | 1 |
| Eguchi, K; Etou, H; Miyachi, S; Morinari, H; Nakada, K; Noda, K; Ohe, Y; Ohkuni, Y; Watanabe, K; Yamada, Y | 1 |
| Bron, D; Carde, P; de Bock, R; De Wolf-Peeters, C; Delmer, A; Keunig, JJ; Keuning, JJ; Somers, R; Thomas, J; Tirelli, U | 1 |
| Ardizzoni, A; Giaccone, G; Haaxma-Reiche, H; Kirkpatrick, A; Postmus, PE; Quoix, E; Sahmoud, T; Smit, EF; van Zandwijk, N | 1 |
| Cascinu, S; Catalano, G; Del Ferro, E; Graziano, F; Ligi, M | 1 |
| Altavilla, G; Brandes, AA; Carollo, C; Chierichetti, F; Ermani, M; Florentino, MV; Rigon, A; Turazzi, S; Zampieri, P | 1 |
| Baker, LH; Fraile, RJ; Samson, MK; Talley, RW | 1 |
| Berendsen, HH; Ousterhuis, BE; Postmus, PE; Sleijfer, DT; Smit, EF | 1 |
| Corringham, R; Corringham, S; Dhaliwal, H; Germond, C; Goss, GD; Kane, G; Rowen, J; Sinoff, C; Vincent, M | 1 |
| Berendsen, HH; Haaxma-Reiche, H; Postmus, PE; Sleijfer, DT; Smit, EF | 1 |
| Dalesio, O; Giaccone, G; Kirkpatrick, A; McVie, JG; Splinter, TA; van Zandwijk, N | 1 |
| Kok, TC; Smit, EF; Splinter, TA | 1 |
| Jakobsen, A; Nielsen, K; Schultz, H; Steenholdt, S; Sørensen, BT | 1 |
| Brunetto, AL; Kalakun, L; Kronfeld, M; Preger, R; Sander, E; Schwartsmann, G; Sprinz, E; Vinholes, J; Zampese, M | 1 |
| Bach, F; Dombernowsky, P; Hansen, HH; Sørensen, JB | 1 |
| Boas, J; Dombernowsky, P; Engelholm, SA; Hansen, OP; Rasmussen, D | 1 |
| Dahl, GV; Grier, HE; Kalwinsky, DK; Mason, C; Mirro, J; Murphy, SB; Santana, VM | 1 |
| Bonardi, GM; Calciati, A; Donadio, M; Giaccone, G; Testore, F | 1 |
| Anderson, J; Bloomfield, CD; Cooper, MR; Ginsberg, SJ; Gottlieb, AJ; Hurd, DD; Lachant, NA | 1 |
86 review(s) available for arginine and Thrombopenia
| Article | Year |
|---|---|
Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review.
Topics: Anticoagulants; Arginine; COVID-19; Critical Illness; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Sepsis; Sulfonamides; Thrombocytopenia; Thrombosis; Venous Thromboembolism | 2022 |
Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis.
Topics: Anticoagulants; Arginine; Bayes Theorem; Heparin; Humans; Middle Aged; Network Meta-Analysis; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2021 |
Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis.
Topics: Arginine; Female; Heparin; Hirudins; Humans; Male; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2017 |
Heparin-induced thrombocytopaenia.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Fondaparinux; Heparin; Heparitin Sulfate; Humans; Pipecolic Acids; Polysaccharides; Sulfonamides; Thrombocytopenia | 2018 |
Argatroban: for a few selected patients.
Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Interactions; Drug Substitution; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Patient Selection; Pipecolic Acids; Risk Assessment; Risk Factors; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis | 2013 |
CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Middle Aged; Pipecolic Acids; Practice Guidelines as Topic; Sulfonamides; Thrombocytopenia | 2015 |
How we manage patients with heparin induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Disease Management; Fondaparinux; Heparin; Humans; Pipecolic Acids; Polysaccharides; Sulfonamides; Thrombocytopenia; Warfarin | 2016 |
Novel oral anticoagulants for heparin-induced thrombocytopenia.
Topics: Administration, Oral; Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2016 |
Heparin-Induced Thrombocytopenia: A Comprehensive Clinical Review.
Topics: Anticoagulants; Antithrombins; Arginine; Cardiopulmonary Bypass; Fondaparinux; Heparin; Hirudins; Humans; Incidence; Peptide Fragments; Percutaneous Coronary Intervention; Pipecolic Acids; Plasmapheresis; Platelet Function Tests; Platelet Transfusion; Polysaccharides; Recombinant Proteins; Risk Factors; Sulfonamides; Thrombocytopenia | 2016 |
[Heparin-induced thrombocytopenia type II (HIT II) : A medical-economic view].
Topics: Arginine; Chondroitin Sulfates; Costs and Cost Analysis; Dermatan Sulfate; Germany; Hemorrhage; Heparin; Heparitin Sulfate; Hospitalization; Humans; Pipecolic Acids; Risk Factors; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2017 |
Heparin-induced thrombocytopenia: a review of current pharmacologic treatment.
Topics: Anticoagulants; Antithrombin III; Arginine; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia | 2008 |
Argatroban use in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Clinical Trials as Topic; Heparin; Humans; Liver; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thromboembolism | 2008 |
Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 2010 |
Heparin-induced thrombocytopenia: what clinicians need to know.
Topics: Anticoagulants; Arginine; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Monitoring; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2009 |
Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Dose-Response Relationship, Drug; Heparin; Humans; International Normalized Ratio; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia; Thrombosis | 2009 |
Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Hirudins; Humans; Male; Monitoring, Physiologic; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Prognosis; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Safety Management; Severity of Illness Index; Sulfonamides; Survival Rate; Thrombocytopenia; Thrombosis; Time Factors | 2009 |
Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis | 2009 |
Heparin-induced thrombocytopenia and cardiac surgery.
Topics: Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Activation; Platelet Count; Platelet Factor 4; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia | 2010 |
Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Topics: Anticoagulants; Arginine; Autoantibodies; Contraindications; Disseminated Intravascular Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombophilia; Time Factors; Venous Thromboembolism; Vitamin K; Warfarin | 2009 |
Argatroban as a substitute of heparin during cardiopulmonary bypass: a safe alternative?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation; Cardiopulmonary Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Heart Valve Prosthesis Implantation; Heparin; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Middle Aged; Pipecolic Acids; Postoperative Hemorrhage; Risk Assessment; Sulfonamides; Thrombin; Thrombocytopenia; Treatment Outcome | 2010 |
Argatroban in the management of heparin-induced thrombocytopenia.
Topics: Adult; Antithrombins; Arginine; Heparin; Humans; Pipecolic Acids; Randomized Controlled Trials as Topic; Sulfonamides; Thrombocytopenia | 2010 |
Pharmacology of argatroban.
Topics: Acute Coronary Syndrome; Antithrombins; Arginine; European Union; Female; Heparin; Humans; Isomerism; Japan; Male; Peptidomimetics; Pipecolic Acids; Stroke; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis; United States | 2010 |
Thrombosis prophylaxis in critically ill patients.
Topics: Anticoagulants; Arginine; Biological Availability; Chromosome Breakage; Chromosome Disorders; Critical Care; Dose-Response Relationship, Drug; Drug Resistance; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Infusions, Intravenous; Injections, Subcutaneous; Pipecolic Acids; Recombinant Proteins; Risk Factors; Sepsis; Severity of Illness Index; Shock, Septic; Sulfonamides; Thrombin; Thrombocytopenia; Venous Thrombosis | 2011 |
An overview of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors | 2010 |
Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective.
Topics: Anticoagulants; Antithrombins; Arginine; Dose-Response Relationship, Drug; Europe; Hematology; Heparin; Humans; Pipecolic Acids; Practice Guidelines as Topic; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2012 |
Outcomes after heparin-induced thrombocytopenia in patients with Propaten vascular grafts.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; California; Coated Materials, Biocompatible; Device Removal; Drug Substitution; Graft Occlusion, Vascular; Heparin; Humans; Ligation; Pipecolic Acids; Prosthesis Design; Reoperation; Risk Assessment; Risk Factors; Sulfonamides; Thrombectomy; Thrombocytopenia; Treatment Outcome | 2012 |
Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Animals; Antithrombins; Arginine; Disease Models, Animal; Drug Evaluation; Heparin; Hirudins; Humans; Peptide Fragments; Percutaneous Coronary Intervention; Pipecolic Acids; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis | 2012 |
Current agents for the treatment of patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Autoimmune Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Warfarin | 2002 |
Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2002 |
[Experimental and clinical results with the thrombin inhibitor Argatroban].
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Coronary Disease; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2002 |
Hirudin in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Blood Coagulation; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors | 2002 |
An overview of the direct thrombin inhibitor argatroban.
Topics: Arginine; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis; Treatment Outcome | 2002 |
Argatroban in HIT type II and acute coronary syndrome.
Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Coronary Disease; Humans; Myocardial Infarction; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2002 |
Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
Topics: Anticoagulants; Antithrombins; Arginine; Female; Heparin; Hirudins; Humans; Middle Aged; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2003 |
Argatroban, a new treatment option for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Blood Coagulation; Blood Coagulation Tests; Chondroitin Sulfates; Critical Care; Dermatan Sulfate; Drug Combinations; Drug Costs; Drug Monitoring; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2003 |
Treatment of heparin-induced thrombocytopenia: a critical review.
Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Risk Assessment; Sulfonamides; Thrombocytopenia; Thrombosis | 2004 |
[Heparin-induced thrombocytopenia in patients on hemodialysis].
Topics: Anticoagulants; Arginine; Benzamidines; Guanidines; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia | 2004 |
Direct thrombin inhibitors in the treatment of immune-mediated heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Binding Sites; Heparin; Hirudins; Humans; Models, Biological; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thrombocytopenia; Treatment Outcome | 2004 |
Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Blood Platelets; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombin; Thrombocytopenia; Time Factors | 2004 |
Heparin-induced thrombocytopenia: diagnosis and management.
Topics: Anticoagulants; Aortic Valve Insufficiency; Arginine; Autoantibodies; Autoimmune Diseases; Female; Fingers; Heart Valve Prosthesis Implantation; Heparin; Hirudins; Humans; Ischemia; Middle Aged; Necrosis; Pipecolic Acids; Platelet Activation; Platelet Factor 4; Postoperative Complications; Raynaud Disease; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Toes; Warfarin | 2004 |
Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
Topics: Administration, Oral; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Hirudins; Humans; Ischemia; Leg; Necrosis; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2005 |
Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.
Topics: Anticoagulants; Arginine; Brain Ischemia; Clinical Trials as Topic; Dose-Response Relationship, Drug; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Risk Factors; Sulfonamides; Thrombin; Thrombocytopenia | 2005 |
An anesthesia provider's perspective of heparin-induced thrombocytopenia.
Topics: Anesthesia, General; Anticoagulants; Arginine; Drug Monitoring; Enzyme-Linked Immunosorbent Assay; Heparin; Hirudins; Humans; Intraoperative Care; Nurse Anesthetists; Pipecolic Acids; Platelet Count; Recombinant Proteins; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors | 2005 |
Heparin-induced thrombocytopenia: principles for early recognition and management.
Topics: Anticoagulants; Arginine; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Platelet Count; Practice Guidelines as Topic; Recombinant Proteins; Risk Assessment; Sulfonamides; Thrombocytopenia; Time Factors | 2005 |
Clinical presentation and laboratory diagnosis of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Hirudins; Humans; Male; Pipecolic Acids; Recombinant Proteins; Risk Assessment; Severity of Illness Index; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2005 |
[Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
Topics: Antibodies; Anticoagulants; Arginine; Biomarkers; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Heparin; Humans; Pipecolic Acids; Platelet Aggregation; Platelet Count; Platelet Factor 4; Sulfonamides; Thrombocytopenia | 2005 |
Evolving management strategies for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Warfarin | 2005 |
Developing an algorithm for treating heparin-induced thrombocytopenia.
Topics: Algorithms; Anticoagulants; Antigen-Antibody Complex; Arginine; Clinical Trials as Topic; Diagnosis, Differential; Disease Management; Follow-Up Studies; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Immunoglobulin G; Pipecolic Acids; Platelet Activation; Platelet Count; Platelet Factor 4; Prognosis; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombophilia; Time Factors | 2004 |
Heparin and other rapidly acting anticoagulants.
Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Embolism; Enzyme Inhibitors; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Venous Thrombosis | 2005 |
Argatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectives.
Topics: Animals; Antithrombins; Arginine; Forecasting; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2006 |
[Argatroban: pharmacological properties and anaesthesiological aspects].
Topics: Anesthesia; Anticoagulants; Antithrombins; Arginine; Coronary Vessels; Critical Care; Extracorporeal Circulation; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Respiration, Artificial; Sulfonamides; Thrombocytopenia | 2006 |
Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Administration Schedule; Factor Xa Inhibitors; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia | 2006 |
Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.
Topics: Angioplasty, Balloon, Coronary; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2006 |
Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions.
Topics: Animals; Anticoagulants; Arginine; Blood Coagulation; Drug Monitoring; Humans; Intracranial Thrombosis; Pipecolic Acids; Randomized Controlled Trials as Topic; Stroke; Sulfonamides; Thrombin; Thrombocytopenia | 2006 |
Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients.
Topics: Adolescent; Anticoagulants; Arginine; Autoantibodies; Cardiopulmonary Bypass; Child; Child, Preschool; Clinical Trials as Topic; Fatal Outcome; Female; Heart Defects, Congenital; Heparin; Hirudins; Hospitals, University; Humans; Hypoplastic Left Heart Syndrome; Infant; Infant, Newborn; Male; Multicenter Studies as Topic; Pipecolic Acids; Platelet Factor 4; Postoperative Complications; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2006 |
[Pharmacotherapy: argatroban--alternative to heparin in case of heparin-induced thrombocytopenia type II (HIT II)].
Topics: Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2006 |
Heparin-induced thrombocytopenia and cardiovascular diseases.
Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sensitivity and Specificity; Sulfonamides; Thrombocytopenia; Thrombosis | 2006 |
Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Critical Care; Dermatan Sulfate; Heparin; Heparinoids; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Platelet Count; Recombinant Proteins; Risk Factors; Sulfonamides; Thrombin; Thrombocytopenia | 2006 |
Heparin-induced thrombocytopenia: advances in diagnosis and treatment.
Topics: Administration, Oral; Anticoagulants; Arginine; Critical Care; Drug Monitoring; Enzyme-Linked Immunosorbent Assay; Heparin; Hirudins; Humans; International Normalized Ratio; Nurse's Role; Nursing Assessment; Partial Thromboplastin Time; Patient Selection; Pipecolic Acids; Platelet Count; Practice Guidelines as Topic; Recombinant Proteins; Risk Factors; Sulfonamides; Syndrome; Thrombocytopenia; Time Factors | 2006 |
Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
Topics: Angioplasty, Balloon, Coronary; Antithrombins; Arginine; Drug Interactions; Economics, Pharmaceutical; Fibrinolytic Agents; Hemorrhage; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis | 2007 |
Heparin-induced thrombocytopenia without thrombosis: an evidence-based review of current literature.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Evidence-Based Medicine; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2006 |
Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
Topics: Ancrod; Anticoagulants; Arginine; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2007 |
Heparin-induced thrombocytopenia in intensive care patients.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Extracorporeal Circulation; Heparin; Heparitin Sulfate; Hirudins; Humans; Intensive Care Units; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis | 2007 |
Heparin-induced thrombocytopenia: treatment options and special considerations.
Topics: Anticoagulants; Antithrombins; Arginine; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis | 2007 |
Anticoagulation options for patients with heparin-induced thrombocytopenia requiring renal support in the intensive care unit.
Topics: Acute Kidney Injury; Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Extracorporeal Circulation; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; Intensive Care Units; Pipecolic Acids; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia | 2007 |
Heparin-induced thrombocytopenia and thrombosis.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis | 2007 |
Heparin induced thrombocytopenia: diagnosis and management update.
Topics: Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin | 2007 |
Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Chondroitin Sulfates; Comorbidity; Dermatan Sulfate; Drug Therapy, Combination; Fibrinolytic Agents; Fondaparinux; Heparin; Heparinoids; Heparitin Sulfate; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Syndrome; Thrombocytopenia; Vitamin K | 2007 |
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.
Topics: Animals; Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2007 |
[Heparin-induced thrombocytopenia].
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2007 |
The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Enzyme-Linked Immunosorbent Assay; Factor Xa Inhibitors; Heparin; Heparitin Sulfate; Hirudins; Peptide Fragments; Pipecolic Acids; Platelet Factor 4; Platelet Function Tests; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia | 2008 |
Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Antibodies; Antithrombins; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1997 |
Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation.
Topics: Anticoagulants; Antithrombin III Deficiency; Antithrombins; Arginine; Contraindications; Extracorporeal Circulation; Granulocytes; Heparin; Humans; Leukocyte Elastase; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 1997 |
[Heparin-induced thrombocytopenia].
Topics: Anticoagulants; Antithrombins; Arginine; Aspirin; Diagnosis, Differential; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Activation; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia; Thrombosis | 1998 |
New treatment options for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; Pipecolic Acids; Randomized Controlled Trials as Topic; Sulfonamides; Thrombocytopenia | 1998 |
Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulation.
Topics: Anticoagulants; Antithrombins; Arginine; Hemostasis; Heparin; Humans; Models, Biological; Pipecolic Acids; Selectins; Sulfonamides; Syndrome; Thrombocytopenia | 1999 |
Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
Topics: Ancrod; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Forecasting; Gangrene; Hemorrhage; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation; Protein C; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 1999 |
Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Critical Pathways; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2000 |
Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Clinical Trials as Topic; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thromboembolism | 2001 |
Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment.
Topics: Anticoagulants; Arginine; Heparin; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Platelet Count; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis | 2001 |
Argatroban.
Topics: Animals; Antithrombins; Arginine; Clinical Trials as Topic; Half-Life; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2001 |
Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
Topics: Abciximab; Ancrod; Antibodies, Monoclonal; Anticoagulants; Arginine; Cardiopulmonary Bypass; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Factor Xa Inhibitors; Hemodilution; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Immunoglobulin Fab Fragments; Perfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Protamines; Sulfonamides; Thrombocytopenia; Thrombophilia; Thrombosis; Tirofiban; Tyrosine | 2001 |
Treatment of heparin-induced thrombocytopenia.
Topics: Animals; Anticoagulants; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Coronary Disease; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Pregnancy; Rabbits; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2002 |
Argatroban.
Topics: Animals; Antithrombins; Arginine; Clinical Trials as Topic; Humans; Pipecolic Acids; Renal Insufficiency; Sulfonamides; Thrombin; Thrombocytopenia | 2002 |
Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Fondaparinux; Heparin; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Prodrugs; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia | 2002 |
Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805).
Topics: Antibodies; Antithrombin III Deficiency; Antithrombins; Arginine; Blood Platelets; Heparin; Heparin Antagonists; Humans; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia | 1992 |
30 trial(s) available for arginine and Thrombopenia
| Article | Year |
|---|---|
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Synthase; Cytarabine; Drug Administration Schedule; Female; Humans; Hydrolases; Injections, Intramuscular; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Polyethylene Glycols; Thrombocytopenia; Treatment Outcome | 2021 |
Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome.
Topics: Arginine; Blood Platelets; Bunyaviridae Infections; CD3 Complex; Dietary Supplements; Humans; Immunity; Immunosuppression Therapy; Metabolome; Metabolomics; Myeloid-Derived Suppressor Cells; Nitric Oxide; Phlebovirus; T-Lymphocytes; Thrombocytopenia | 2018 |
Evaluation of 2 nomogram-based strategies for dosing argatroban in patients with known or suspected heparin-induced thrombocytopenia.
Topics: Aged; Antithrombins; Arginine; Female; Heparin; Humans; Male; Middle Aged; Nomograms; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2015 |
Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Arginine; Critical Illness; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Recombinant Proteins; Renal Insufficiency; Renal Replacement Therapy; Sulfonamides; Surgical Procedures, Operative; Thrombocytopenia | 2014 |
Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Female; Heparin; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2015 |
Argatroban pharmacokinetics and pharmacodynamics in critically ill cardiac surgical patients with suspected heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Cardiac Surgical Procedures; Critical Illness; Female; Half-Life; Heparin; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Prospective Studies; Sulfonamides; Thrombocytopenia | 2016 |
Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
Topics: Anticoagulants; Arginine; Female; Heparin; Hirudins; Humans; Male; Pilot Projects; Pipecolic Acids; Prospective Studies; Recombinant Proteins; Research Design; Sulfonamides; Thrombocytopenia; Thrombosis | 2010 |
A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
Topics: Adolescent; Adult; Aged; Anticoagulants; Arginine; Disease Progression; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Middle Aged; Pilot Projects; Pipecolic Acids; Platelet Count; Postoperative Complications; Postoperative Period; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis; Treatment Outcome; Young Adult | 2011 |
Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia.
Topics: Adult; Aged; Antithrombins; Arginine; Empirical Research; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Nomograms; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2011 |
Evaluation of a standardized protocol using lepirudin or argatroban for heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2011 |
Monitoring of argatroban in ARG310 study: potential recommendations for its use in interventional cardiology.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Tests; Chromatography, High Pressure Liquid; Drug Monitoring; Endopeptidases; Heparin; Humans; Pipecolic Acids; Point-of-Care Systems; Stents; Sulfonamides; Thrombocytopenia | 2002 |
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Coronary Disease; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis | 2005 |
Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Humans; Infusions, Intravenous; International Normalized Ratio; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Prospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2005 |
Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
Topics: Adult; Aged; Amputation, Surgical; Arginine; Cause of Death; Female; Hemorrhage; Heparin; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Pipecolic Acids; Retrospective Studies; Risk Assessment; Sulfonamides; Survival Rate; Thrombocytopenia; Thrombosis; Treatment Outcome; Warfarin | 2005 |
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Drug Administration Schedule; Female; Heparin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pipecolic Acids; Prospective Studies; Renal Replacement Therapy; Retrospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2005 |
Thrombocytopenia following heparin flush.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Catheters, Indwelling; Cause of Death; Diagnosis, Differential; Female; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Patient Selection; Pipecolic Acids; Platelet Count; Prospective Studies; Recurrence; Sulfonamides; Therapeutic Irrigation; Thrombocytopenia; Thrombosis; Treatment Outcome | 2005 |
Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: first results from the ARG-E03 trial.
Topics: Antibodies; Anticoagulants; Arginine; Cardiopulmonary Bypass; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Postoperative Care; Sulfonamides; Thrombocytopenia | 2006 |
Argatroban anticoagulation in critically ill patients.
Topics: Anticoagulants; Arginine; Critical Illness; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Multiple Organ Failure; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2007 |
Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arginine; Creatine; Female; Heparin; Humans; Male; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Risk Factors; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2007 |
Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
Topics: Acute Disease; Aged; Anticoagulants; Arginine; Female; Heparin; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Retrospective Studies; Safety; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2007 |
Additional anticoagulant strategies for managing heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia | 1996 |
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Tests; Diarrhea; Exanthema; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pain; Pipecolic Acids; Purpura; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2001 |
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oligodendroglioma; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome | 2003 |
A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Teniposide; Thrombocytopenia; Treatment Outcome | 1994 |
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome; Vincristine | 1994 |
Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Cranial Irradiation; Europe; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Remission Induction; Teniposide; Thrombocytopenia; Tomography, X-Ray Computed | 1995 |
Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Combined Modality Therapy; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Multivariate Analysis; Necrosis; Nitrosourea Compounds; Proportional Hazards Models; Radiation Injuries; Radiotherapy Dosage; Survival Analysis; Survival Rate; Teniposide; Thrombocytopenia; Treatment Outcome | 1998 |
Teniposide (VM-26) and carboplatin as initial therapy for small cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Teniposide; Thrombocytopenia | 1992 |
The European Organization for Research and Treatment of Cancer experience with teniposide: preliminary results of a randomized study in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Synergism; Europe; Humans; Lung Neoplasms; Remission Induction; Teniposide; Thrombocytopenia | 1992 |
Treatment of extensive small cell lung cancer with carboplatin and teniposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Teniposide; Thrombocytopenia | 1991 |
280 other study(ies) available for arginine and Thrombopenia
| Article | Year |
|---|---|
Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Dabigatran; Drug Therapy, Combination; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Venous Thrombosis | 2022 |
Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia.
Topics: Adult; Aged; Arginine; Factor Xa Inhibitors; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Sulfonamides; Thrombocytopenia | 2022 |
Laboratory methods for monitoring argatroban in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; COVID-19; Drug Monitoring; Heparin; Humans; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2022 |
[Low-dose argatroban emerging salvage therapies for heparin-induced thrombocytopenia during artificial liver treatment: a case report].
Topics: Anticoagulants; Arginine; Heparin; Humans; Liver, Artificial; Pipecolic Acids; Salvage Therapy; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2021 |
Atrial Fibrillation in a Patient with Heparin-induced Thrombocytopenia Successfully Treated by Radiofrequency Catheter Ablation Using a Direct Thrombin Inhibitor.
Topics: Aged; Antithrombins; Arginine; Atrial Fibrillation; Catheter Ablation; Heparin; Humans; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2022 |
A journey through anticoagulant therapies in the treatment of left ventricular thrombus in post-COVID-19 heparin-induced thrombocytopenia: a case report.
Topics: Acenocoumarol; Anticoagulants; Arginine; COVID-19; COVID-19 Drug Treatment; Heparin; Hirudins; Humans; Male; Middle Aged; Peptide Fragments; Percutaneous Coronary Intervention; Pipecolic Acids; Recombinant Proteins; SARS-CoV-2; Sulfonamides; Thrombocytopenia; Thrombosis | 2022 |
Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2022 |
How to dose and monitor argatroban for treatment of HIT.
Topics: Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2022 |
Argatroban Versus Bivalirudin in the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2021 |
Preoperative and intraoperative argatroban as anticoagulant for bridging a patient with heparin-induced thrombocytopaenia to lung transplantation.
Topics: Aged; Anticoagulants; Arginine; Heparin; Humans; Lung Transplantation; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2020 |
Argatroban dosing requirements in extracorporeal life support and other critically ill populations.
Topics: Anticoagulants; Arginine; Cohort Studies; Critical Illness; Extracorporeal Membrane Oxygenation; Heparin; Humans; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2020 |
Lung transplantation using argatroban in severe heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a case series.
Topics: Anticoagulants; Arginine; Extracorporeal Membrane Oxygenation; Heparin; Humans; Lung Transplantation; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2020 |
Myocardial Infarction with Limb Arterial and Venous Thrombosis in a Patient with Enoxaparin-Induced Thrombocytopenia.
Topics: Aged; Antithrombins; Arginine; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Pipecolic Acids; Pyrazoles; Pyridones; ST Elevation Myocardial Infarction; Sulfonamides; Thrombocytopenia; Thrombosis | 2020 |
Argatroban as Purge Solution in Patients With Heparin-Induced Thrombocytopenia on an Impella Device.
Topics: Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2020 |
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Betacoronavirus; Blood Coagulation; Coronavirus Infections; COVID-19; Heparin; Host-Pathogen Interactions; Humans; Male; Pandemics; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2020 |
Unexpectedly Low Fibrinogen.
Topics: Antithrombins; Arginine; Blood Chemical Analysis; Fibrinogen; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2020 |
[Complex management of type 2 heparin-induced thrombocytopenia in patients with major bleeding tendency: two case report].
Topics: 4-Hydroxycoumarins; Aged; Anticoagulants; Arginine; Blood Coagulation Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hemorrhage; Heparin; Humans; Indenes; Intracranial Thrombosis; Male; Middle Aged; Neurosurgical Procedures; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Vitamin K | 2020 |
Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series.
Topics: Aged; Anticoagulants; Arginine; Canada; Female; Fondaparinux; Gastrointestinal Neoplasms; Hematologic Neoplasms; Hemorrhage; Heparin; Humans; Male; Patient Acuity; Pipecolic Acids; Platelet Count; Retrospective Studies; Risk Adjustment; Sulfonamides; Thrombocytopenia | 2021 |
A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT).
Topics: Aged; Anticoagulants; Arginine; Heparin; Humans; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia; Warfarin | 2021 |
Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Equivalence Trials as Topic; Extracorporeal Membrane Oxygenation; Female; Germany; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Propensity Score; Prospective Studies; Registries; Sulfonamides; Thrombocytopenia | 2021 |
Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Topics: Antithrombins; Arginine; Cerebral Veins; ChAdOx1 nCoV-19; COVID-19 Vaccines; Drug Therapy, Combination; Female; Fondaparinux; Humans; Immunoglobulins, Intravenous; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Tomography, X-Ray Computed; Venous Thrombosis; Young Adult | 2021 |
Use of an argatroban systemic infusion and purge solution in a patient with a percutaneous ventricular assist device with suspected heparin-induced thrombocytopenia.
Topics: Adult; Arginine; Heart-Assist Devices; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2022 |
Monitoring of Argatroban and Lepirudin: What is the Input of Laboratory Values in "Real Life"?
Topics: Antithrombins; Arginine; Blood Coagulation Tests; Drug Monitoring; Heparin; Hirudins; Humans; Partial Thromboplastin Time; Pipecolic Acids; Prothrombin Time; Recombinant Proteins; Sulfonamides; Thrombin Time; Thrombocytopenia | 2018 |
Use of an argatroban-based purge solution in a percutaneous ventricular assist device.
Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Drug Substitution; Female; Heart-Assist Devices; Heparin; Humans; Pipecolic Acids; Shock, Cardiogenic; Sulfonamides; Takotsubo Cardiomyopathy; Thrombocytopenia; Treatment Outcome | 2017 |
Response to: "More on the Limitations of the aPTT for Monitoring Argatroban Therapy".
Topics: Anticoagulants; Arginine; Heparin; Humans; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2017 |
More on the Limitations of the Activated Partial Thromboplastin Time for Monitoring Argatroban Therapy.
Topics: Anticoagulants; Arginine; Heparin; Humans; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2017 |
Argatroban for Heparin-Induced Thrombocytopenia during Venovenous Extracorporeal Membrane Oxygenation with Continuous Venovenous Hemofiltration.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Dose-Response Relationship, Drug; Extracorporeal Membrane Oxygenation; Hemofiltration; Heparin; Humans; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2017 |
Treatment of pulmonary embolism with argatroban and ultrasound-assisted catheter-directed thrombolysis with alteplase in a patient with heparin-induced thrombocytopenia.
Topics: Aged; Arginine; Catheterization; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Interventional | 2017 |
Argatroban in Thrombocytopenic Patients Sensitized to Circulating Protamine-Heparin Complexes.
Topics: Adult; Arginine; Autoantibodies; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Protamines; Sulfonamides; Thrombocytopenia | 2017 |
Thrombolysis for acute pulmonary embolism after major hepatic surgery.
Topics: Acute Disease; Adenocarcinoma; Appendiceal Neoplasms; Arginine; Atrial Fibrillation; Bronchoscopy; Catheters; Colectomy; Computed Tomography Angiography; Diagnosis, Differential; Electric Countershock; Fibrinolytic Agents; Heparin; Hepatectomy; Humans; Infusions, Intravenous; Intubation, Intratracheal; Liver Neoplasms; Lung; Male; Middle Aged; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Troponin I; Ultrasonography; Venous Thrombosis | 2017 |
Anticoagulation of Percutaneous Ventricular Assist Device Using Argatroban-Based Purge Solution: A Case Series.
Topics: Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation; Drug Monitoring; Female; Heart-Assist Devices; Heparin; Humans; Male; Middle Aged; Pharmaceutical Solutions; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia | 2018 |
Idiopathic catastrophic thrombosis with happy ending.
Topics: Anticoagulants; Antithrombins; Arginine; Awareness; Blood Coagulation Tests; Coronary Artery Bypass; Heparin; Humans; Male; Middle Aged; Phenprocoumon; Pipecolic Acids; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome; Ultrasonography; Venous Thrombosis | 2017 |
Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia.
Topics: Anticoagulants; Arginine; Female; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Thrombosis; Venous Thrombosis | 2017 |
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Female; Fondaparinux; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Hospital Mortality; Hospitalization; Humans; Male; Necrosis; Off-Label Use; Partial Thromboplastin Time; Patient Safety; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Registries; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2017 |
Heparin-Induced Thrombocytopenia during Obstetric Hospital Admissions.
Topics: Adolescent; Adult; Arginine; Databases, Factual; Delivery, Obstetric; Female; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Hospitalization; Humans; Middle Aged; Peptide Fragments; Pipecolic Acids; Postpartum Period; Pregnancy; Recombinant Proteins; Risk Assessment; Sulfonamides; Thrombocytopenia; United States; Young Adult | 2018 |
Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
Topics: Antibodies; Anticoagulants; Antithrombins; Arginine; Blood Coagulation; Blood Coagulation Tests; Cardiac Surgical Procedures; Drug Monitoring; Female; Heart Defects, Congenital; Heparin; Humans; Infant; Male; Pipecolic Acids; Platelet Factor 4; Predictive Value of Tests; Risk Factors; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2019 |
Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia.
Topics: Aged; Arginine; Fondaparinux; Heparin; Humans; Middle Aged; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism | 2018 |
An infrequent complication of a not so infrequent disease. Hit by HIT.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Antithrombins; Aortic Valve; Arginine; Drug Substitution; Echocardiography, Transesophageal; Electrocardiography; Extracorporeal Membrane Oxygenation; Fatal Outcome; Heart Arrest; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Heparin; Humans; Male; Pipecolic Acids; Sulfonamides; Thrombectomy; Thrombocytopenia; Thrombosis; Treatment Outcome | 2019 |
Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study.
Topics: Adult; Aged; Anticoagulants; Arginine; Critical Care; Diagnosis, Differential; Extracorporeal Membrane Oxygenation; Female; France; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Prevalence; Retrospective Studies; Shock, Cardiogenic; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2018 |
Reversible Auricular Necrosis Secondary to Systemic Thrombosis.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Ear Auricle; Ear Diseases; Female; Heparin; Humans; Necrosis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis | 2018 |
Use of argatroban for extracorporeal life support in patients with nonheparin-induced thrombocytopenia: Analysis of 10 consecutive patients.
Topics: Adult; Antithrombins; Arginine; Blood Coagulation Tests; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Male; Middle Aged; Patient Care Management; Pipecolic Acids; Platelet Count; Republic of Korea; Retrospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2018 |
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
Topics: Administration, Oral; Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Evidence-Based Medicine; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Recombinant Proteins; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia; Venous Thromboembolism | 2018 |
High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
Topics: Anticoagulants; Arginine; Arthroplasty, Replacement, Knee; Female; Fondaparinux; Gastrointestinal Hemorrhage; Heparin; Humans; Immunoglobulins, Intravenous; Middle Aged; Pipecolic Acids; Platelet Activation; Platelet Count; Serotonin; Sulfonamides; Thrombocytopenia; Thrombosis; Venous Thromboembolism | 2019 |
Sepsis-induced heparin resistance during extracorporeal membrane oxygenation.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Drug Resistance; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Pipecolic Acids; Sepsis; Sulfonamides; Thrombocytopenia | 2019 |
High frequency of false-positive results of aPTT-based lupus anticoagulant tests in patients receiving argatroban.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Female; Heparin; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2019 |
Inpatient management strategies in a severe case of heparin-induced thrombocytopenia.
Topics: Aged; Arginine; Coronary Artery Bypass; Female; Fondaparinux; Heparin; Humans; Pipecolic Acids; Platelet Count; Platelet Transfusion; Sulfonamides; Thrombocytopenia; Venous Thrombosis | 2019 |
Alternative monitoring of argatroban using plasma-diluted thrombin time.
Topics: Aged, 80 and over; Arginine; Drug Monitoring; Humans; Liver Diseases; Male; Pipecolic Acids; Sulfonamides; Thrombin Time; Thrombocytopenia | 2013 |
[Management of cardiopulmonary bypass during cardiac surgery for patients with heparin-induced thrombocytopenia].
Topics: Aged; Antithrombins; Arginine; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Whole Blood Coagulation Time | 2013 |
[Open heart surgery using cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia(HIT)].
Topics: Aged; Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Stenosis; Heparin; Humans; Male; Mitral Valve; Mitral Valve Insufficiency; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia | 2013 |
Non-recovery of ACT in a patient with heparin-induced thrombocytopenia type II during mitral valve replacement using argatroban anticoagulation.
Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Cardiopulmonary Bypass; Female; Heart Valve Prosthesis Implantation; Heparin; Humans; Mitral Valve; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Whole Blood Coagulation Time | 2013 |
Heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Sulfonamides; Thrombocytopenia; Venous Thrombosis | 2013 |
Role of argatroban during neurointerventional procedures in patients with heparin induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Cerebral Angiography; Cerebrovascular Disorders; Combined Modality Therapy; Endovascular Procedures; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2014 |
Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Cardiac Surgical Procedures; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2014 |
The dosing and monitoring of argatroban for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a word of caution.
Topics: Adult; Antithrombins; Arginine; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2014 |
Thrombosis of biatrial appendages due to heparin-induced thrombocytopenia.
Topics: Aged, 80 and over; Antibodies; Anticoagulants; Arginine; Arterial Occlusive Diseases; Atrial Appendage; Atrial Fibrillation; Biomarkers; Coronary Artery Bypass; Drug Administration Schedule; Drug Substitution; Female; Heart Diseases; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombectomy; Thrombocytopenia; Thrombosis; Tomography, X-Ray Computed | 2013 |
Heparin-induced thrombocytopenia and the health economic analysis of argatroban.
Topics: Arginine; Cost-Benefit Analysis; Drug Costs; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia; United Kingdom | 2014 |
Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Polycystic Kidney Diseases; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin | 2015 |
[Recipient of living kidney transplantation during which heparin-induced thrombocytopenia (HIT) was suspected: a case report].
Topics: Aged; Anesthesia, General; Anticoagulants; Antithrombins; Arginine; Diabetic Nephropathies; Drug Substitution; Female; Heparin; Humans; Kidney Transplantation; Living Donors; Perioperative Care; Pipecolic Acids; Postoperative Complications; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2014 |
Use of argatroban and catheter-directed thrombolysis with alteplase in an oncology patient with heparin-induced thrombocytopenia with thrombosis.
Topics: Antithrombins; Arginine; Autografts; Catheterization; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis | 2014 |
Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Arginine; Female; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Male; Middle Aged; Odds Ratio; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Registries; Retrospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2014 |
Heparin-induced thrombocytopenia in haemodialysis treated with argatroban.
Topics: Aged; Antithrombins; Arginine; Heparin; Humans; Male; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia | 2014 |
Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite "Therapeutic" Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding.
Topics: Adult; Antithrombins; Aortic Valve Stenosis; Arginine; Fatal Outcome; Fibrinolytic Agents; Heart Valve Prosthesis Implantation; Heparin; Humans; Infusions, Intravenous; Male; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis; Whole Blood Coagulation Time | 2015 |
Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database.
Topics: Adolescent; Age Factors; Antithrombins; Arginine; Child; Child, Preschool; Databases, Factual; Female; Health Information Systems; Hemorrhage; Hirudins; Humans; Incidence; Infant; Infant, Newborn; Infusions, Parenteral; Male; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Young Adult | 2014 |
Pulmonary embolism and heparin-induced thrombocytopenia successfully treated with tissue plasminogen activator and argatroban.
Topics: Antithrombins; Arginine; Female; Fibrinolytic Agents; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Tissue Plasminogen Activator | 2015 |
Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2015 |
Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.
Topics: Adult; Aged; Anticoagulants; Arginine; Critical Illness; Dose-Response Relationship, Drug; Drug Costs; Female; Germany; Health Care Costs; Hemorrhage; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism | 2015 |
Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.
Topics: Amputation, Surgical; Animals; Anticoagulants; Arginine; Drug Evaluation, Preclinical; Hemorrhage; Hemostasis; Heparin; Male; NG-Nitroarginine Methyl Ester; Peptide Fragments; Proteins; Rats, Wistar; Thrombocytopenia; Warfarin | 2015 |
Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Peptide Fragments; Pipecolic Acids; Practice Guidelines as Topic; Prospective Studies; Recombinant Proteins; Sulfonamides; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2015 |
Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Arginine; Cohort Studies; Extracorporeal Circulation; Female; Heart Failure; Heart-Assist Devices; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Prosthesis Implantation; Sulfonamides; Thrombocytopenia; Thrombosis | 2015 |
Minimal Prolongation of Prothrombin Time with Extended Exposure to Argatroban.
Topics: Anticoagulants; Antithrombins; Arginine; Carcinoma, Squamous Cell; Drug Substitution; Female; Heparin; Humans; International Normalized Ratio; Mandibular Neoplasms; Middle Aged; Mouth Mucosa; Pipecolic Acids; Prothrombin Time; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis; Treatment Failure; Warfarin | 2015 |
Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Dose-Response Relationship, Drug; Female; Hemorrhage; Heparin; Hirudins; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2015 |
[Monitoring of 4 patients with heparin-induced thrombocytopenia after complex congenital heart surgery].
Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Heparin; Humans; Incidence; Infant; Pipecolic Acids; Platelet Count; Prognosis; Sulfonamides; Thrombocytopenia; Thrombosis | 2015 |
Early recognition is the key to success: pulseless electrical activity (PEA) as a manifestation of heparin-induced anaphylactoid reaction.
Topics: Anticoagulants; Arginine; Arrhythmias, Cardiac; Cardiopulmonary Resuscitation; Early Diagnosis; Heart Valve Prosthesis Implantation; Heparin; Humans; Male; Middle Aged; Mitral Valve; Pipecolic Acids; Platelet Count; Platelet Function Tests; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2015 |
Challenging Argatroban Management of a Child on Extracorporeal Support and Subsequent Heart Transplant.
Topics: Antithrombins; Arginine; Cardiopulmonary Bypass; Child; Exchange Transfusion, Whole Blood; Extracorporeal Membrane Oxygenation; Heart Transplantation; Heparin; Hirudins; Humans; Male; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2016 |
Heparin-Induced-Thrombocytopenia Causing Massive Aortic Thrombosis after Ascending Aortic Replacement for Type A Acute Aortic Dissection.
Topics: Acute Disease; Aged; Anticoagulants; Aortic Aneurysm; Aortic Diseases; Aortic Dissection; Aortography; Arginine; Blood Vessel Prosthesis Implantation; Computed Tomography Angiography; Drug Substitution; Emergencies; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Mesenteric Ischemia; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors; Treatment Outcome | 2016 |
Argatroban monitoring: aPTT versus chromogenic assay.
Topics: Arginine; Blood Coagulation; Blood Coagulation Tests; Drug Monitoring; Humans; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia | 2016 |
Argatroban for anticoagulation of a blood salvage system - an ex-vivo study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation; Blood Transfusion; Dose-Response Relationship, Drug; Female; Hematocrit; Heparin; Humans; In Vitro Techniques; Male; Middle Aged; Operative Blood Salvage; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2016 |
Argatroban for Treatment of Heparin-Induced Thrombocytopenia and Thrombosis in a Patient with Multiple Myeloma Undergoing Hemodialysis.
Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Arginine; Dalteparin; Female; Humans; Multiple Myeloma; Partial Thromboplastin Time; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia; Venous Thrombosis | 2016 |
Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU.
Topics: Academic Medical Centers; Aged; Antibodies; Anticoagulants; Antithrombins; Arginine; Enzyme-Linked Immunosorbent Assay; Female; Fondaparinux; Heparin; Hirudins; Humans; Intensive Care Units; Male; Medical Overuse; Middle Aged; Pipecolic Acids; Platelet Factor 4; Polysaccharides; Prospective Studies; Recombinant Proteins; Serotonin; Sulfonamides; Thrombocytopenia | 2017 |
Successful Anticoagulation Using Argatroban During Transcatheter Aortic Valve Implantation in a Patient With Heparin-Induced Thrombocytopenia.
Topics: Aged, 80 and over; Anticoagulants; Arginine; Heparin; Humans; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Transcatheter Aortic Valve Replacement | 2016 |
Monitoring anticoagulation with argatroban in critically ill patients: activated partial thromboplastin time versus diluted thrombin time.
Topics: Anticoagulants; Arginine; Critical Illness; Humans; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombin Time; Thrombocytopenia | 2016 |
Recurrent heparin-induced thrombocytopenia due to heparin rinsing before priming the machine in a hemodialysis patient: A case report.
Topics: Aged, 80 and over; Anticoagulants; Arginine; Female; Heparin; Humans; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia | 2017 |
Rapid and durable response to intravenous immunoglobulin in delayed heparin-induced thrombocytopenia: a case report.
Topics: Arginine; Cardiac Surgical Procedures; Heparin; Hirudins; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis | 2017 |
Heparin-induced thrombocytopenia with aortoiliac thrombosis treated with argatroban.
Topics: Anticoagulants; Antithrombins; Aortic Diseases; Arginine; Heparin; Humans; Iliac Artery; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis | 2017 |
Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Angioplasty; Anticoagulants; Arginine; Female; Heparin; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2008 |
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Anticoagulants; Arginine; Biological Availability; Chondroitin Sulfates; Dermatan Sulfate; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Infusions, Parenteral; Injections, Subcutaneous; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2008 |
What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Female; Heart Diseases; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia; Whole Blood Coagulation Time | 2008 |
Complete salvage of impending free flap failure in heparin induced thrombocytopenia by emergent institution of therapy with argatroban.
Topics: Anastomosis, Surgical; Anticoagulants; Arginine; Carcinoma, Squamous Cell; Female; Graft Rejection; Heparin; Humans; Middle Aged; Mouth Neoplasms; Pipecolic Acids; Reoperation; Salvage Therapy; Sulfonamides; Surgical Flaps; Thrombocytopenia; Thrombosis; Veins | 2008 |
Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
Topics: Analysis of Variance; Anticoagulants; Antithrombin III; Arginine; Autoantibodies; Enoxaparin; Flow Cytometry; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Morpholines; Pipecolic Acids; Platelet Activation; Platelet Aggregation; Platelet Factor 4; Polysaccharides; Rivaroxaban; Sulfonamides; Thiophenes; Thrombocytopenia | 2008 |
Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.
Topics: Adult; Arginine; Fibrinolytic Agents; Heart-Assist Devices; Heparin; Humans; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Sulfonamides; Thrombocytopenia | 2008 |
Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation.
Topics: Adult; Anticoagulants; Arginine; Autoantibodies; Heart Failure; Heart Transplantation; Heparin; Hirudins; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2008 |
Heparin-induced thrombocytopenia (HIT) causing pulmonary emboli during coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Disseminated Intravascular Coagulation; Embolectomy; Heparin; Humans; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Tomography, X-Ray Computed; Vena Cava Filters | 2008 |
A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience.
Topics: Aged; Anticoagulants; Arginine; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2009 |
Dosing patterns and outcomes in African American, Asian, and Hispanic patients with heparin-induced thrombocytopenia treated with argatroban.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Asian; Black or African American; Female; Fibrinolytic Agents; Heparin; Hispanic or Latino; Humans; Male; Middle Aged; Pipecolic Acids; Prospective Studies; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thrombosis | 2009 |
INR matters: a case on managing argatroban for bridging oral anticoagulation in a patient with heparin induced thrombocytopenia type II after mechanical heart valve replacement.
Topics: Aged; Anticoagulants; Aortic Valve; Arginine; Female; Heart Valve Prosthesis Implantation; Heparin; Humans; International Normalized Ratio; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2009 |
Argatroban for anticoagulation in continuous renal replacement therapy.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Arginine; Critical Illness; Female; Heparin; Humans; Male; Pipecolic Acids; Prospective Studies; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia | 2009 |
Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation; Drug Monitoring; Female; Hemorrhage; Heparin; Humans; Lung Diseases; Male; Middle Aged; Odds Ratio; Partial Thromboplastin Time; Pipecolic Acids; Retrospective Studies; Risk Assessment; Risk Factors; Sulfonamides; Thrombocytopenia; Thrombosis; Young Adult | 2008 |
"Drug dosing in the intensive care unit: the critically ill are a special population too".
Topics: Anticoagulants; Arginine; Critical Illness; Heparin; Humans; Intensive Care Units; Pipecolic Acids; Renal Insufficiency; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia | 2009 |
Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.
Topics: Adult; Aged; Anticoagulants; Arginine; Cohort Studies; Critical Illness; Dose-Response Relationship, Drug; Female; Heparin; Humans; Male; Middle Aged; Multiple Organ Failure; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2009 |
Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Body Weight; Dose-Response Relationship, Drug; Female; Heparin; Humans; Male; Middle Aged; Nomograms; Pipecolic Acids; Prospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2009 |
84-year-old woman with hemodialysis-associated shortness of breath.
Topics: Aged, 80 and over; Anticoagulants; Arginine; Autoantibodies; Dyspnea; Echocardiography; Female; Heparin; Humans; Hypotension; Hypoxia; Pipecolic Acids; Platelet Activation; Platelet Aggregation; Platelet Factor 4; Renal Dialysis; Sulfonamides; Thrombocytopenia | 2009 |
[Use of argatroban during cardiopulmonary bypass for atrial septal defect with heparin induced thrombocytopenia after introduction of dialysis].
Topics: Adult; Anticoagulants; Arginine; Cardiopulmonary Bypass; Female; Heart Septal Defects, Atrial; Heparin; Humans; Intraoperative Care; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia; Whole Blood Coagulation Time | 2009 |
Heparin-induced thrombocytopenia in two patients undergoing abdominal aortic aneurysm surgery.
Topics: Aged; Anticoagulants; Aortic Aneurysm, Abdominal; Arginine; Autoantibodies; Disseminated Intravascular Coagulation; Heparin; Humans; Male; Mesenteric Arteries; Pipecolic Acids; Platelet Factor 4; Postoperative Complications; Sulfonamides; Thrombocytopenia; Thrombosis | 2010 |
[Argatroban treatment of heparin-induced immune-mediated thrombocytopenia].
Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia | 2009 |
[Heparin-induced thrombocytopenia].
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Risk Factors; Sulfonamides; Thrombocytopenia | 2009 |
A report of outcomes after orthotopic liver transplant with allografts from heparin antibody-positive donors.
Topics: Algorithms; Antibodies; Anticoagulants; Arginine; Clinical Protocols; Female; Heparin; Humans; Liver Transplantation; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis; Tissue Donors; Transplantation, Homologous; Young Adult | 2009 |
Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study.
Topics: Anticoagulants; Arginine; Diagnostic Techniques, Cardiovascular; Drug Therapy, Combination; Feasibility Studies; Heart Diseases; Heart-Assist Devices; Heparin; Hirudins; Humans; In Vitro Techniques; Infusion Pumps; Male; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis | 2009 |
Impact of renal function on argatroban therapy during percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Clinical Trials as Topic; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Renal Insufficiency; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2010 |
Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spinal; Anticoagulants; Arginine; Female; Fondaparinux; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Polysaccharides; Pregnancy; Sulfonamides; Thrombocytopenia | 2010 |
HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.
Topics: Anticoagulants; Arginine; Cardiopulmonary Bypass; Drug Therapy, Combination; Heart-Assist Devices; Heparin; Humans; Iloprost; Length of Stay; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Prosthesis Design; Prosthesis Implantation; Sulfonamides; Thrombocytopenia; Warfarin | 2009 |
[Clinical observation of heparin-induced thrombocytopenia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Venous Thromboembolism; Young Adult | 2009 |
Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arginine; Critical Care; Dose-Response Relationship, Drug; Female; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2009 |
[Anesthetic management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
Topics: Aged; Anesthesia; Angina Pectoris; Anticoagulants; Arginine; Coronary Artery Bypass, Off-Pump; Heparin; Humans; Infusions, Intravenous; Intraoperative Care; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2009 |
Heparin-induced thrombocytopenia with multiple organized thrombi accompanied by unusual cholesterin deposition: autopsy case after long-term follow up.
Topics: Aged; Anticoagulants; Arginine; Embolism, Cholesterol; Fatal Outcome; Heparin; Humans; Male; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2009 |
[Heparin-induced thrombocytopenia type II with thrombosis in an intensive care patient: therapy management using the direct thrombin inhibitor argatroban].
Topics: Aged; Anticoagulants; Aortic Aneurysm, Abdominal; Aortic Rupture; Arginine; Exanthema; Heparin; Humans; Male; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis | 2009 |
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis.
Topics: Aged; Arginine; Blood Coagulation Disorders; Cardiopulmonary Bypass; Child; Heart Transplantation; Heparin; Humans; Infusions, Intravenous; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia; Thrombosis | 2010 |
Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report.
Topics: Acute Kidney Injury; Adult; Anticoagulants; Arginine; Heparin; Humans; Male; Obesity, Morbid; Pipecolic Acids; Renal Replacement Therapy; Respiratory Distress Syndrome; Shock, Septic; Sulfonamides; Thrombocytopenia | 2010 |
Difficult management of anticoagulation with argatroban in a patient undergoing on-pump cardiac surgery.
Topics: Aged; Anticoagulants; Arginine; Cardiac Surgical Procedures; Disease Management; Female; Humans; International Normalized Ratio; Pipecolic Acids; Postoperative Hemorrhage; Sulfonamides; Thrombocytopenia | 2010 |
Treatment with argatroban in one haemodialysed patient with a heparin-induced thrombocytopenia and thrombotic complications.
Topics: Aged, 80 and over; Arginine; Female; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Renal Dialysis; Sulfonamides; Thrombocytopenia; Thrombosis | 2010 |
Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Arginine; Critical Care; Dose-Response Relationship, Drug; Female; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Pipecolic Acids; Retrospective Studies; Sulfonamides; Survival Analysis; Thrombocytopenia | 2010 |
Serious acute coronary thrombosis associated with heparin-induced thrombocytopenia in off-pump coronary artery bypass grafting.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Bypass, Off-Pump; Coronary Thrombosis; Female; Graft Occlusion, Vascular; Heparin; Humans; Pipecolic Acids; Stents; Sulfonamides; Thrombocytopenia; Time Factors; Treatment Outcome | 2010 |
[Heparin-induced thrombocytopenia after on-pump coronary artery bypass grafting].
Topics: Anticoagulants; Arginine; Coronary Artery Bypass; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Postoperative Complications; Sulfonamides; Thrombocytopenia | 2010 |
Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
Topics: Aged, 80 and over; Anticoagulants; Arginine; Coronary Artery Bypass; Female; Fondaparinux; Heparin; Humans; Mitral Valve; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Polysaccharides; Renal Dialysis; Sulfonamides; Thrombocytopenia; Venous Thrombosis | 2010 |
A patient with 'spontaneous' heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement.
Topics: Anticoagulants; Antithrombins; Arginine; Arthroplasty, Replacement, Knee; Autoantibodies; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Sulfonamides; Thrombocytopenia; Venous Thrombosis | 2011 |
Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
Topics: Antithrombins; Arginine; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Time Factors | 2010 |
Thrombolytic therapy and thrombectomy in phlegmasia cerulea dolens.
Topics: Anticoagulants; Antithrombins; Arginine; Fibrinolytic Agents; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombectomy; Thrombocytopenia; Time Factors; Venous Thrombosis | 2010 |
Extracorporeal membrane oxygenation bridging to lung transplant complicated by heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Arginine; Extracorporeal Membrane Oxygenation; Fatal Outcome; Heparin; Humans; Lung Transplantation; Male; Multiple Organ Failure; Pipecolic Acids; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Sulfonamides; Thrombocytopenia; Time Factors; Treatment Outcome | 2010 |
[Interventional lung assist membrane ventilator. Successful use despite heparin-induced thrombocytopenia type II].
Topics: Aged; Anticoagulants; Arginine; Extracorporeal Membrane Oxygenation; Heparin; Humans; Lung Neoplasms; Male; Perioperative Care; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome; Respiratory Insufficiency; Smoking; Sulfonamides; Thrombocytopenia | 2011 |
Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT "overdiagnosis" in a patient with antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Diagnostic Errors; Drug Monitoring; Fatal Outcome; Female; Gangrene; Hemorrhage; Humans; Lung Diseases; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Upper Extremity; Vascular Diseases; Warfarin | 2011 |
Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
Topics: Aged; Anticoagulants; Arginine; Atrial Fibrillation; Blood Coagulation Tests; Carotid Stenosis; Endarterectomy, Carotid; Female; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Warfarin | 2011 |
Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Cardiac Catheterization; Cardiac Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Male; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vascular Surgical Procedures; Vitamin K; Young Adult | 2011 |
Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study.
Topics: Anticoagulants; Arginine; Child; Child, Preschool; Female; Hemorrhage; Heparin; Humans; Infant; Liver Function Tests; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Prospective Studies; Sulfonamides; Survival Rate; Thrombocytopenia; Thrombosis; Tissue Distribution; Treatment Outcome | 2011 |
Hypereosinophilic syndrome with cardiac involvement in a pregnant patient with multiple sclerosis.
Topics: Adult; Anticoagulants; Arginine; Drug Substitution; Female; Glucocorticoids; Heparin; Humans; Hypereosinophilic Syndrome; Multiple Sclerosis; Pipecolic Acids; Prednisone; Pregnancy; Pregnancy Complications, Cardiovascular; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2011 |
[Diagnosis and treatment of heparin-induced thrombocytopenia].
Topics: Acute Kidney Injury; Aged; Anticoagulants; Antithrombins; Aortic Valve Stenosis; Arginine; Diagnosis, Differential; Hand; Heparin; Humans; Ischemia; Male; Pipecolic Acids; Platelet Count; Renal Dialysis; Shock, Cardiogenic; Sulfonamides; Thrombocytopenia; Ventricular Dysfunction, Left | 2011 |
Heparin-induced thrombocytopenia type II because of heparin-coated polytetrafluoroethylene graft used to bypass.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Device Removal; Early Diagnosis; Female; Heparin; Humans; Lower Extremity; Pipecolic Acids; Polytetrafluoroethylene; Prosthesis Design; Reoperation; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2011 |
Management of argatroban surrounding a lumbar puncture: a case report.
Topics: Aged; Antithrombins; Arginine; Female; Humans; Partial Thromboplastin Time; Pipecolic Acids; Seizures; Spinal Puncture; Sulfonamides; Thrombocytopenia; Time Factors; Treatment Outcome | 2011 |
Identifying patient- and treatment-related factors related to amputation risk in cases of heparin-induced thrombocytopenia treated with argatroban.
Topics: Aged; Amputation, Surgical; Anticoagulants; Antithrombins; Arginine; Chi-Square Distribution; Clinical Trials as Topic; Female; Heparin; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pipecolic Acids; Retrospective Studies; Risk Assessment; Risk Factors; Sulfonamides; Thrombocytopenia; Time Factors; Treatment Failure | 2011 |
Left ventricular thrombus during cardiopulmonary bypass as the primary manifestation of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Cardiopulmonary Bypass; Echocardiography, Transesophageal; Heparin; Humans; Intraoperative Complications; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Sulfonamides; Thrombocytopenia; Thromboembolism; Ventricular Dysfunction, Left | 2013 |
Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol.
Topics: Academic Medical Centers; Anticoagulants; Antithrombins; Arginine; Heparin; Hirudins; Humans; Joint Commission on Accreditation of Healthcare Organizations; Patient Education as Topic; Pharmacists; Pipecolic Acids; Practice Guidelines as Topic; Quality Assurance, Health Care; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; United States | 2012 |
Nitric oxide activity in platelets of dengue haemorrhagic fever patients: the apparent paradoxical role of ADMA and l-NMMA.
Topics: Adult; Arginine; Blood Platelets; Brazil; Enzyme Inhibitors; Female; Humans; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Aggregation; Severe Dengue; Thrombocytopenia | 2012 |
Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
Topics: Antibodies; Anticoagulants; Arginine; Cardiac Surgical Procedures; Drug Substitution; Georgia; Hemorrhage; Heparin; Humans; Intensive Care Units; Pipecolic Acids; Platelet Factor 4; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Sulfonamides; Thoracic Surgical Procedures; Thrombocytopenia; Thrombosis; Time Factors; Treatment Outcome | 2012 |
Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
Topics: Adult; Aged; Anticoagulants; Arginine; Feasibility Studies; Female; Heart Transplantation; Heart-Assist Devices; Heparin; Hospital Mortality; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2012 |
Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Blood Coagulation Disorders, Inherited; Female; Heparin; Humans; Male; Pipecolic Acids; Pregnancy; Pregnancy Complications, Hematologic; Sulfonamides; Thrombocytopenia; Venous Thrombosis | 2012 |
High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
Topics: Anticoagulants; Arginine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Heparin; Humans; International Normalized Ratio; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia; Thrombosis | 2012 |
Heparin-induced thrombocytopenia in essential thrombocytosis.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Bone Marrow Examination; Cerebral Infarction; Constriction, Pathologic; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Femoral Artery; Heparin; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Predictive Value of Tests; Sulfonamides; Thrombocythemia, Essential; Thrombocytopenia; Thrombophlebitis; Treatment Outcome | 2012 |
[Anesthesia for a hemodialysis patient with HIT undergoing CABG using argatroban].
Topics: Aged, 80 and over; Anesthesia, General; Anticoagulants; Antithrombins; Arginine; Coronary Artery Bypass; Heparin; Humans; Male; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia | 2012 |
The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome.
Topics: Aged; Arginine; Female; Fondaparinux; Heparin; Humans; Immunoenzyme Techniques; Inflammation; Pipecolic Acids; Platelet Factor 4; Polysaccharides; Sulfonamides; Syndrome; Thrombocytopenia; Treatment Outcome | 2012 |
Choice of drugs for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; Pipecolic Acids; Polysaccharides; Sulfonamides; Thrombocytopenia | 2012 |
Treatment outcomes of heparin-induced thrombocytopenia in subarachnoid hemorrhage patients: a 4-year, retrospective single-center review.
Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Anticoagulants; Arginine; Female; Fondaparinux; Heparin; Humans; Immunoglobulin G; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Factor 4; Polysaccharides; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Subarachnoid Hemorrhage; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2012 |
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2012 |
Alternative anticoagulation during cardiovascular procedures in pediatric patients with heparin-induced thrombocytopenia.
Topics: Antithrombins; Arginine; Cardiopulmonary Bypass; Heparin; Hirudins; Humans; Infant; Infant, Newborn; Male; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2012 |
Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Arginine; Female; Heparin; Hirudins; Humans; International Normalized Ratio; Male; Middle Aged; Peptide Fragments; Pipecolic Acids; Platelet Count; Recombinant Proteins; Renal Replacement Therapy; Retrospective Studies; Serum Albumin; Sulfonamides; Thrombocytopenia | 2012 |
Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
Topics: Anticoagulants; Antithrombins; Arginine; End Stage Liver Disease; Heparin; Humans; Kidney Failure, Chronic; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia | 2012 |
Safety and effectiveness outcomes of an inpatient collaborative drug therapy management service for direct thrombin inhibitors.
Topics: Adult; Aged; Antithrombins; Arginine; Cohort Studies; Cooperative Behavior; Drug Monitoring; Female; Hemorrhage; Heparin; Hirudins; Humans; Inpatients; Male; Medication Errors; Middle Aged; Outcome Assessment, Health Care; Partial Thromboplastin Time; Peptide Fragments; Pharmacists; Pharmacy Service, Hospital; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Time Factors | 2012 |
Effects of argatroban, danaparoid, and fondaparinux on trombin generation in heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Platelets; Calibration; Chondroitin Sulfates; Dermatan Sulfate; Female; Fondaparinux; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Pipecolic Acids; Plasma; Platelet-Rich Plasma; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Time Factors | 2013 |
[Heparin-induced thrombocytopenia: the clinical picture and treatment].
Topics: Anticoagulants; Arginine; Autoantibodies; Heparin; Humans; Pipecolic Acids; Platelet Aggregation; Sulfonamides; Thrombocytopenia | 2002 |
Comment: treatment of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 2002 |
Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anticoagulants; Arginine; Autoimmune Diseases; Catheterization, Central Venous; Contraindications; Drug Administration Schedule; Drug Therapy, Combination; Female; Gangrene; Heparin; Hirudin Therapy; Hirudins; Humans; International Normalized Ratio; Leg; Male; Middle Aged; Necrosis; Pipecolic Acids; Protein C Deficiency; Recombinant Proteins; Sulfonamides; Surgical Wound Infection; Thrombin; Thrombocytopenia; Thrombophlebitis; Warfarin | 2002 |
Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
Topics: Adult; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Atherectomy, Coronary; Female; Heparin; Humans; Male; Pipecolic Acids; Stents; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2002 |
Argatroban for percutaneous coronary interventions: hit or miss?
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis | 2002 |
Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2002 |
Direct antithrombin agents ameliorate disseminated intravascular coagulation in suspected heparin-induced thrombocytopenia thrombosis syndrome.
Topics: Adult; Aged; Arginine; Disseminated Intravascular Coagulation; Female; Fibrinolytic Agents; Heparin; Hirudins; Humans; Male; Middle Aged; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2002 |
Acute pulmonary thromboembolism induced by prophylactic heparin use and a heparin-coated catheter: a case of heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Acute Disease; Anticoagulants; Arginine; Catheterization; Catheterization, Central Venous; Coated Materials, Biocompatible; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Radionuclide Imaging; Sulfonamides; Syndrome; Thrombocytopenia; Thromboembolism; Tomography, X-Ray Computed; Ultrasonography | 2003 |
Argatroban in adult extracorporeal membrane oxygenation.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Coated Materials, Biocompatible; Enzyme-Linked Immunosorbent Assay; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Pipecolic Acids; Sulfonamides; Texas; Thrombocytopenia | 2002 |
Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Cardiopulmonary Bypass; Female; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2003 |
Hemostatic analysis of a patient undergoing off-pump coronary artery bypass surgery with argatroban anticoagulation.
Topics: Aged; Anticoagulants; Arginine; Colitis; Coronary Artery Bypass; Fatal Outcome; Fibrinogen; Hemostasis; Heparin; Humans; International Normalized Ratio; Male; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Prothrombin Time; Sulfonamides; Thrombelastography; Thrombin; Thrombocytopenia; Whole Blood Coagulation Time | 2003 |
Excessive argatroban anticoagulation for heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Critical Illness; Drug Overdose; Female; Heparin; Humans; Liver Function Tests; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2003 |
Successful use of Argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Cardiopulmonary Bypass; Female; Heparin; Humans; Pipecolic Acids; Risk Factors; Sulfonamides; Thrombin Time; Thrombocytopenia; Whole Blood Coagulation Time | 2003 |
Obstinate thrombosis during percutaneous coronary intervention in a case with heparin-induced thrombocytopenia with thrombosis syndrome successfully treated by argatroban anticoagulant therapy.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Cardiac Catheterization; Coronary Stenosis; Coronary Thrombosis; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Pipecolic Acids; Radiography; Risk Assessment; Sulfonamides; Syndrome; Thrombocytopenia; Treatment Outcome | 2003 |
Direct thrombin inhibitors during PCI.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Coronary Stenosis; Coronary Thrombosis; Follow-Up Studies; Heparin; Humans; Myocardial Infarction; Pipecolic Acids; Radiography; Risk Assessment; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2003 |
Heparin-induced thrombocytopenia--recognition and treatment.
Topics: Anticoagulants; Arginine; Heparin; Hirudin Therapy; Humans; Nursing Assessment; Perioperative Nursing; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2003 |
Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Topics: Acute Disease; Adult; Anticoagulants; Arginine; Fatal Outcome; Heparin; Humans; Infusions, Intravenous; Liver Failure; Male; Pipecolic Acids; Renal Dialysis; Renal Insufficiency; Sulfonamides; Thrombocytopenia; Venous Thrombosis | 2003 |
Vascular surgery using argatroban in a patient with a history of heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Heparin; Humans; Male; Perioperative Care; Peripheral Vascular Diseases; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2003 |
Treatment options for heparin-induced thrombocytopenia.
Topics: Antithrombins; Arginine; Heparin; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; United States | 2003 |
Argatroban use during pediatric interventional cardiac catheterization.
Topics: Antithrombins; Arginine; Cardiac Catheterization; Child; Embolization, Therapeutic; Fibrinolytic Agents; Heart Diseases; Heparin; Humans; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis | 2004 |
Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII.
Topics: Anticoagulants; Arginine; Coronary Artery Bypass; Factor VII; Factor VIIa; Heparin; Humans; Infant; Male; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2004 |
Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction.
Topics: Acute Kidney Injury; Aged; Arginine; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heparin; Humans; Infusions, Parenteral; International Normalized Ratio; Liver Diseases; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia; Transaminases | 2004 |
Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy.
Topics: Aged; Anticoagulants; Arginine; Cerebral Infarction; Critical Care; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heparin; Hospital Mortality; Humans; Intracranial Embolism; Male; Middle Aged; Odds Ratio; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Sulfonamides; Survival Rate; Thrombocytopenia | 2004 |
Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Blood Coagulation; Cardiopulmonary Bypass; Extracorporeal Membrane Oxygenation; Fatal Outcome; Heparin; Humans; Hypoplastic Left Heart Syndrome; Infant, Newborn; Pipecolic Acids; Postoperative Care; Sulfonamides; Thrombocytopenia | 2004 |
Heparin-induced thrombocytopenia and thrombosis in a patient with polycythemia vera.
Topics: Aged; Arginine; Female; Follow-Up Studies; Heparin; Humans; Japan; Pipecolic Acids; Polycythemia Vera; Pulmonary Embolism; Risk Assessment; Severity of Illness Index; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2004 |
Monitoring direct thrombin inhibitors: time for standardization.
Topics: Anticoagulants; Arginine; Coronary Artery Bypass; Factor VII; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombocytopenia; Whole Blood Coagulation Time | 2004 |
[Use of argatroban as a substitute for heparin in a patient with suspected HIT type II undergoing carotid endarterectomy].
Topics: Aged; Anesthesia, Inhalation; Anesthesia, Intravenous; Anticoagulants; Arginine; Carotid Artery, Internal; Endarterectomy, Carotid; Female; Heparin; Humans; Monitoring, Intraoperative; Pipecolic Acids; Preoperative Care; Sulfonamides; Thrombocytopenia; Whole Blood Coagulation Time | 2004 |
Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Arginine; Blood Coagulation Disorders; Heart Valve Prosthesis Implantation; Heparin; Humans; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis | 2004 |
Argatroban as a heparin substitute in cases of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Heparin; Humans; International Normalized Ratio; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2004 |
Spontaneous atrioventricular groove disruption during off-pump coronary artery bypass grafting.
Topics: Aged; Anticoagulants; Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass, Off-Pump; Coronary Stenosis; Emergencies; Fatal Outcome; Female; Heart Injuries; Heparin; Humans; Hypertension, Pulmonary; Internal Mammary-Coronary Artery Anastomosis; Intraoperative Complications; Mitral Valve; Myocardial Infarction; Pipecolic Acids; Postoperative Complications; Rupture, Spontaneous; Sulfonamides; Suture Techniques; Thrombocytopenia; Thromboembolism | 2005 |
Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Prospective Studies; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia | 2005 |
Direct thrombin inhibitors in heparin-induced thrombocytopenia.
Topics: Antithrombins; Arginine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; International Normalized Ratio; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2005 |
The use of argatroban for carotid endarterectomy in heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Aortic Aneurysm, Abdominal; Arginine; Blood Coagulation Tests; Endarterectomy, Carotid; Female; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2005 |
Argatroban for anticoagulation during cardiopulmonary bypass in an infant.
Topics: Anti-Bacterial Agents; Antibodies; Anticoagulants; Arginine; Cardiopulmonary Bypass; Drug Hypersensitivity; Endocarditis, Bacterial; Heparin; Hepatomegaly; Humans; Infant; Intraoperative Complications; Male; Pipecolic Acids; Splenomegaly; Sulfonamides; Thrombocytopenia; Tricuspid Valve | 2005 |
Effect of argatroban on the activated partial thromboplastin time: a comparison of 21 commercial reagents.
Topics: Arginine; Blood Coagulation; Dose-Response Relationship, Drug; Drug Monitoring; Heparin; Humans; Partial Thromboplastin Time; Pipecolic Acids; Reagent Kits, Diagnostic; Sensitivity and Specificity; Sulfonamides; Thrombocytopenia | 2005 |
Coagulation management of a patient with factor V Leiden mutation, lupus anticoagulant, and activated protein C resistance: a case report.
Topics: Activated Protein C Resistance; Adult; Anticoagulants; Arginine; Coronary Stenosis; Factor V; Female; Heparin, Low-Molecular-Weight; Humans; Intraoperative Care; Lupus Coagulation Inhibitor; Pipecolic Acids; Postoperative Care; Sulfonamides; Thrombocytopenia | 2005 |
Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
Topics: Aged; Antibodies; Anticoagulants; Arginine; Enzyme-Linked Immunosorbent Assay; Female; Heparin; Hirudin Therapy; Hirudins; Humans; Immunoglobulin G; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2005 |
Toxicity of argatroban overdose in a 65-year-old man.
Topics: Aged; Arginine; Drug Overdose; Heart Valve Diseases; Humans; Male; Medical Errors; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2005 |
Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.
Topics: Amino Acid Substitution; Anemia; Arginine; Child, Preschool; DNA-Binding Proteins; Erythroid-Specific DNA-Binding Factors; Erythropoiesis; Female; GATA1 Transcription Factor; Glycine; Humans; Megakaryocytes; Pedigree; Point Mutation; Thrombocytopenia; Thrombopoiesis; Transcription Factors | 2005 |
The paradox of heparin-induced thrombocytopenia: the initial management.
Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2005 |
Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Child; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Heparin; Hirudins; Humans; Partial Thromboplastin Time; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2005 |
Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Cohort Studies; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Platelet Activation; Platelet Aggregation; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2005 |
Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Drug Administration Schedule; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome; Warfarin | 2005 |
Successful recovery after an overdose of argatroban.
Topics: Aged; Anticoagulants; Arginine; Blood Component Transfusion; Drug Overdose; Humans; Male; Medication Errors; Pipecolic Acids; Plasma; Sulfonamides; Thrombin; Thrombocytopenia; Treatment Outcome | 2006 |
Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban.
Topics: Anticoagulants; Arginine; Extracorporeal Membrane Oxygenation; Heparin; Humans; Infant; Male; Pipecolic Acids; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia | 2006 |
[A case of heparin-induced thrombocytopenia associated with unexpected excessive argatroban anticoagulation after abdominal aortic aneurysm resection].
Topics: Aged; Anticoagulants; Aortic Aneurysm, Abdominal; Arginine; Heparin; Humans; Intraoperative Complications; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2006 |
Heparin-induced thrombocytopenia and cardiovascular patients: recognition and treatment.
Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Factor 4; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2006 |
Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombin; Thrombocytopenia; Time Factors; Treatment Outcome | 2006 |
Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Arginine; Female; Fondaparinux; Heparin; Humans; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Polysaccharides; Sulfonamides; Thrombocytopenia; Thrombosis | 2006 |
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
Topics: Aged; Anticoagulants; Arginine; Bilirubin; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heparin; Humans; Liver Diseases; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2006 |
Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
Topics: Anticoagulants; Antithrombins; Arginine; Cardiopulmonary Bypass; Child; Dose-Response Relationship, Drug; Fatal Outcome; Female; Fibrinolytic Agents; Heart Transplantation; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombelastography; Thrombocytopenia; Treatment Failure; Whole Blood Coagulation Time | 2006 |
Cardiac surgery in a patient with heparin-induced thrombocytopenia--cautions with use of the direct thrombin inhibitor, argatroban.
Topics: Aged, 80 and over; Anticoagulants; Aortic Valve Stenosis; Arginine; Contraindications; Coronary Artery Bypass; Female; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Sulfonamides; Thrombocytopenia | 2006 |
Thrombotic end point for assessing argatroban therapy for heparin-induced thrombocytopenia: learning from secondary analyses of prospective studies.
Topics: Anticoagulants; Arginine; Cohort Studies; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2006 |
Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.
Topics: Aged; Amputation, Surgical; Anticoagulants; Arginine; Cohort Studies; Controlled Clinical Trials as Topic; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2006 |
[Two cases of heparin-induced thrombocytopenia (HIT) and a review of the literature].
Topics: Aged; Antibodies; Arginine; Female; Heart Failure; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
Topics: Adult; Aged; Amputation, Surgical; Anticoagulants; Arginine; Dose-Response Relationship, Drug; Female; Heparin; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Registries; Renal Dialysis; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2006 |
Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Cohort Studies; Creatinine; Dose-Response Relationship, Drug; Female; Heparin; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2006 |
Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Arginine; Drug Therapy, Combination; Female; Gastric Bypass; Heparin; Humans; International Normalized Ratio; Obesity, Morbid; Partial Thromboplastin Time; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
Hydroxyethyl starch enhances argatroban-mediated decreases in clot propagation and strength by diminishing thrombin-fibrinogen interactions.
Topics: Anticoagulants; Arginine; Blood Coagulation; Cardiopulmonary Bypass; Drug Synergism; Fibrinogen; Hemostasis; Heparin; Humans; Hydroxyethyl Starch Derivatives; Pipecolic Acids; Protein Binding; Sulfonamides; Thrombin; Thrombocytopenia | 2007 |
[Two surgical case reports showing atypical heparin-induced thrombocytopenia].
Topics: Adult; Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Eruptions; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Male; Pipecolic Acids; Platelet Count; Platelet Factor 4; Postoperative Complications; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors | 2007 |
Argatroban for anticoagulation in pediatric patients with heparin-induced thrombocytopenia requiring extracorporeal life support.
Topics: Anticoagulants; Arginine; Extracorporeal Circulation; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Newborn; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2007 |
Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery.
Topics: Acute Kidney Injury; Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia | 2007 |
Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Body Weight; Female; Heparin; Humans; Male; Obesity; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Retrospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2007 |
Effect of body mass index on Argatroban therapy during percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Blood Coagulation; Body Mass Index; Coronary Artery Disease; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Obesity; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2008 |
Argatroban in extracorporeal membrane oxygenation.
Topics: Adult; Anticoagulants; Arginine; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Respiratory Distress Syndrome; Sulfonamides; Thrombocytopenia | 2007 |
Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Drug Therapy, Combination; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2008 |
Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatroban.
Topics: Aged; Arginine; Blood Coagulation Tests; Extremities; Heparin; Humans; Ischemia; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator | 2007 |
Influence of argatroban on coagulation parameters in heparin-induced thrombocytopenia patients after cardiothoracic surgery.
Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Coronary Artery Bypass; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2007 |
Argatroban therapy in patients with coronary artery disease and heparin-induced thrombocytopenia.
Topics: Aged; Amputation, Surgical; Anticoagulants; Arginine; Case-Control Studies; Cause of Death; Coronary Artery Disease; Female; Heparin; Humans; Male; Pipecolic Acids; Prospective Studies; Statistics, Nonparametric; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2008 |
Factor Va, bound to microparticles released during platelet storage, is resistant to inactivation by activated protein C.
Topics: Arginine; Blood Coagulation; Blood Platelets; Blood Preservation; Electrophoresis, Polyacrylamide Gel; Factor Va; Hemostasis; Humans; Protein C; Thrombocytopenia; Thromboplastin | 2007 |
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome".
Topics: Arginine; Blood Platelets; GATA1 Transcription Factor; Genes, X-Linked; Glutamine; Humans; Mutation; Syndrome; Terminology as Topic; Thalassemia; Thrombocytopenia | 2007 |
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence.
Topics: Arginine; Female; Headache; Heparin, Low-Molecular-Weight; Hirudins; Humans; Middle Aged; Pipecolic Acids; Recombinant Proteins; Seizures; Sulfonamides; Thrombocytopenia | 2007 |
Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Cholangiopancreatography, Endoscopic Retrograde; Female; Half-Life; Heparin; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Middle Aged; Peritoneal Dialysis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2008 |
A case of heparin-induced thrombocytopenia with repeated episodes of acute lower extremity arterial thromboembolism during a short time.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Leg; Middle Aged; Pipecolic Acids; Recurrence; Sulfonamides; Thrombectomy; Thrombocytopenia; Thromboembolism | 2007 |
Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Catheterization, Peripheral; Fibrinolytic Agents; Heparin; Humans; Infusions, Intra-Arterial; Lower Extremity; Male; Pipecolic Acids; Radiography; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome | 2007 |
Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arginine; Benzamidines; Female; Guanidines; Heparin; Humans; Male; Middle Aged; Peritoneal Dialysis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Uremia | 2008 |
Heparin-induced thrombocytopenia complicating hemodialysis.
Topics: Adult; Anticoagulants; Arginine; Calciphylaxis; Drug Contamination; Female; Heparin; Humans; Necrosis; Pipecolic Acids; Renal Dialysis; Renal Insufficiency; Skin Diseases; Sulfonamides; Thrombocytopenia; Warfarin | 2008 |
Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.
Topics: Adult; Anticoagulants; Arginine; Blood Coagulation; Heparin; Humans; Male; Partial Thromboplastin Time; Pipecolic Acids; Prothrombin Time; Sulfonamides; Thrombelastography; Thrombocytopenia; Time Factors | 2008 |
[Patient with heparin-induced thrombocytopenia type II and implanted left ventricular assist device].
Topics: Aged; Anticoagulants; Arginine; Female; Heart-Assist Devices; Heparin; Humans; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Factor 4; Sulfonamides; Thrombocytopenia | 2008 |
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
Topics: Acute Disease; Anticoagulants; Arginine; Blood Coagulation; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Platelet Count; Polysaccharides; Recombinant Proteins; Research Design; Sulfonamides; Thrombin; Thrombocytopenia; Treatment Outcome; Venous Thrombosis; Warfarin | 2008 |
Standardizing the management of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Clinical Protocols; Evidence-Based Medicine; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Count; Platelet Function Tests; Polysaccharides; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2008 |
Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock.
Topics: Anticoagulants; Arginine; Fatal Outcome; Female; Hemofiltration; Heparin; Humans; Middle Aged; Multiple Organ Failure; Pipecolic Acids; Shock, Septic; Sulfonamides; Thrombocytopenia | 2008 |
Reduced argatroban doses after coronary artery bypass graft surgery.
Topics: Aged; Aged, 80 and over; Arginine; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pipecolic Acids; Postoperative Complications; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2008 |
[Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
Topics: Acute Kidney Injury; Anticoagulants; Arginine; Blood Coagulation Tests; Chondroitin Sulfates; Citrates; Critical Care; Dermatan Sulfate; Diagnostic Errors; Dose-Response Relationship, Drug; Epoprostenol; Fondaparinux; Hemofiltration; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Iloprost; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sodium Citrate; Sulfonamides; Thrombocytopenia; Thrombosis | 2008 |
Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices.
Topics: Anticoagulants; Arginine; Autoantibodies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Heart Transplantation; Heart-Assist Devices; Heparin; Humans; Kruppel-Like Transcription Factors; Partial Thromboplastin Time; Pipecolic Acids; Postoperative Care; Postoperative Complications; Prosthesis Design; Repressor Proteins; Retrospective Studies; Sulfonamides; Survival Rate; Thrombin; Thrombocytopenia | 2008 |
Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices. Invited commentary.
Topics: Anticoagulants; Arginine; Autoantibodies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart-Assist Devices; Heparin; Humans; Infusions, Intravenous; Kruppel-Like Transcription Factors; Pipecolic Acids; Postoperative Complications; Postoperative Hemorrhage; Prosthesis Design; Repressor Proteins; Retrospective Studies; Risk Factors; Sulfonamides; Thrombin; Thrombocytopenia | 2008 |
Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation.
Topics: Animals; Arginine; Creatinine; Female; Fetal Growth Retardation; gamma-Glutamyltransferase; Hematocrit; Hypertension; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Count; Potassium; Pregnancy; Pregnancy Complications; Proteinuria; Rats; Rats, Wistar; Sodium; Thrombocytopenia | 1994 |
NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs.
Topics: Animals; Antineoplastic Agents; Arginine; Blood Pressure; Blood Urea Nitrogen; Cell Division; Creatinine; Dogs; Enzymes; Glioma; Hypotension; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukocyte Count; Lymphocytes; Male; Monocytes; Nitric Oxide; omega-N-Methylarginine; Thrombocytopenia; Tumor Cells, Cultured | 1994 |
Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus.
Topics: Adolescent; Adult; Alleles; Arginine; Base Sequence; Child; Child, Preschool; Exons; Female; Gene Expression; Humans; Infant; Male; Molecular Sequence Data; Mutation; Phenotype; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proteins; Thrombocytopenia; Wiskott-Aldrich Syndrome; Wiskott-Aldrich Syndrome Protein | 1995 |
Scanning of the Wiskott-Aldrich syndrome (WAS) gene: identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype.
Topics: Adult; Amino Acid Sequence; Arginine; Base Sequence; Child; Child, Preschool; Chromosome Mapping; Codon; Frameshift Mutation; Humans; Introns; Phenotype; Point Mutation; Polymorphism, Single-Stranded Conformational; Proteins; Sequence Deletion; Thrombocytopenia; Wiskott-Aldrich Syndrome; Wiskott-Aldrich Syndrome Protein; X Chromosome | 1995 |
On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia.
Topics: Antibodies; Antigens, CD; Arginine; Base Sequence; Genotype; Heparin; Histidine; Humans; Molecular Sequence Data; Phenotype; Platelet Activation; Platelet Aggregation; Receptors, IgG; Thrombocytopenia | 1995 |
Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Coronary Angiography; Coronary Disease; Female; Heparin; Humans; Myocardial Infarction; Pipecolic Acids; Platelet Aggregation Inhibitors; Stents; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1996 |
Novastan anticoagulation during renal stent implant in a patient with heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Coronary Artery Bypass; Heparin; Humans; Intraoperative Complications; Kidney; Male; Pipecolic Acids; Stents; Sulfonamides; Thrombocytopenia | 1997 |
Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Blood Coagulation Factors; Blood Coagulation Tests; Drug Monitoring; Drug Therapy, Combination; Factor X; False Positive Reactions; Female; Heparin; Humans; Indicators and Reagents; Male; Pipecolic Acids; Prothrombin Time; Reference Values; Reproducibility of Results; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 1997 |
The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Carotid Arteries; Carotid Stenosis; Catheterization; Cerebrovascular Disorders; Femoral Artery; Follow-Up Studies; Heparin; Humans; Male; Paresis; Pipecolic Acids; Platelet Aggregation Inhibitors; Recurrence; Stents; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1998 |
Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Antigens, CD; Arginine; Female; Heparin; Histidine; Humans; Male; Middle Aged; Polymorphism, Genetic; Receptors, IgG; Thrombocytopenia | 1998 |
Effective anticoagulation by argatroban during coronary stent implantation in a patient with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Coronary Disease; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Stents; Sulfonamides; Thrombocytopenia | 1997 |
Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Coronary Disease; Drug Evaluation; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis | 1999 |
Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Anticoagulants; Antithrombins; Arginine; Blood Platelets; Drug Therapy, Combination; Female; Heparin; Hirudin Therapy; Humans; Immunoglobulin Fab Fragments; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thrombocytopenia; Tirofiban; Tyrosine | 1999 |
Heparin-induced thrombocytopenia in coronary bypass surgery.
Topics: Anticoagulants; Arginine; Coronary Artery Bypass; Heparin; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Risk Factors; Sulfonamides; Thrombocytopenia | 1999 |
Argatroban approved for heparin-induced thrombocytopenia.
Topics: Antithrombins; Arginine; Half-Life; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2000 |
Argatroban for treatment of heparin-induced thrombocytopenia.
Topics: Arginine; Health Expenditures; Hemorrhage; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis | 2001 |
Anticoagulation with a selective thrombin inhibitor in a woman with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Catheterization, Central Venous; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Postoperative Complications; Sulfonamides; Thrombectomy; Thrombocytopenia; Thrombosis | 2001 |
[Intraoperative management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
Topics: Aged; Antithrombins; Arginine; Coronary Artery Bypass; Fibrinolytic Agents; Heparin; Humans; Intraoperative Care; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2002 |
Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia.
Topics: Antibodies; Anticoagulants; Arginine; Dose-Response Relationship, Drug; Heparin; Humans; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis | 2002 |
Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor.
Topics: Aged; Antithrombins; Arginine; Blood Platelets; Female; Heparin; Humans; Immunoglobulin G; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 1992 |
Anticoagulant therapy with MD805 of a hemodialysis patient with heparin-induced thrombocytopenia.
Topics: Aged; Antithrombins; Arginine; Heparin; Humans; Male; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia | 1990 |
Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysis.
Topics: Arginine; Blood Platelets; Heparin; Humans; Immunoglobulin G; Pipecolic Acids; Platelet Aggregation; Renal Dialysis; Sulfonamides; Thrombin; Thrombocytopenia | 1988 |
[Clinical evaluation of MD-805].
Topics: Aged; Antithrombins; Arginine; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Fibrinopeptide A; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Renal Dialysis; Sulfonamides; Thrombocytopenia; Thrombosis | 1987 |
A new thrombin inhibitor MD805 and thrombocytopenia encountered with heparin hemodialysis.
Topics: Aged; Arginine; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Platelet Aggregation; Renal Dialysis; Sulfonamides; Thrombin; Thrombocytopenia; Thromboxane B2 | 1986 |
[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas].
Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Child; Cisplatin; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Nausea; Neutropenia; Nimustine; Temozolomide; Teniposide; Thrombocytopenia; Young Adult | 2011 |
[Treatment of malignant non-Hodgkin's lymphoma. Economic impact of rituximab (Mabthera) versus conventional chemotherapy].
Topics: Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Drug Hypersensitivity; Female; Hospitalization; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Retrospective Studies; Rituximab; Teniposide; Thrombocytopenia; Vincristine; Vomiting | 2003 |
A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients.
Topics: Adult; Age Factors; Aged; Asthenia; Drug Evaluation; Female; Humans; Leukopenia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1984 |
Phase II study of VM-26 in adult malignancies.
Topics: Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Podophyllotoxin; Teniposide; Thrombocytopenia | 1980 |
The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Bone Marrow; Carcinoma, Small Cell; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Nausea; Neoplasm Staging; Remission Induction; Survival Rate; Teniposide; Thrombocytopenia; Vomiting | 1997 |
VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Thrombocytopenia | 1978 |
Phase I study of oral teniposide (VM-26).
Topics: Administration, Oral; Adult; Aged; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Remission Induction; Teniposide; Thrombocytopenia; Vomiting | 1992 |
Treatment of brain metastases of small cell lung cancer with teniposide.
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials, Phase II as Topic; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Teniposide; Thrombocytopenia | 1992 |
A phase I study of daily oral teniposide for 20 days.
Topics: Administration, Oral; Aged; Bone Marrow; Clinical Trials, Phase I as Topic; Drug Administration Schedule; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms; Teniposide; Thrombocytopenia; Vomiting | 1992 |
Phase II study of teniposide in patients with AIDS-related Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alopecia; Drug Evaluation; Humans; Leukopenia; Male; Nausea; Sarcoma, Kaposi; Teniposide; Thrombocytopenia; Time Factors | 1991 |
Phase II study of teniposide in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Remission Induction; Teniposide; Thrombocytopenia | 1991 |
Phase II study of teniposide in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1990 |
Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukopenia; Male; Mouth Mucosa; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Stomatitis; Teniposide; Thrombocytopenia | 1989 |
Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
Topics: Aged; Brain Neoplasms; Carcinoma, Small Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1988 |
Treatment of refractory lymphoma with methotrexate, VM-26 (teniposide), procarbazine, and dexamethasone: Cancer and Leukemia Group B study 7902.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Female; Humans; Leucovorin; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Procarbazine; Teniposide; Thrombocytopenia; Vincristine | 1988 |